Abstract
Aucklandia lappa Decne. (ALD), a synonym of Saussurea costus (Falc.) Lipsch., is a traditional Chinese medicinal herb extensively cultivated in China. Aucklandiae Radix (AR, known as “Muxiang” in China), derived from the dried root of ALD, holds a significant position in the clinical application of traditional Chinese medicine, encompassing the enhancement of gastrointestinal motility, antibacterial properties, and antitumor activities. Notably, AR possesses a complex and diverse chemical composition, with costunolide and dehydrocostus lactone being its core active metabolites. This review provides an in-depth exploration of the biological characteristics, cultivation techniques, ethnopharmacology, phytochemistry, pharmacological activities, and processing techniques associated with ALD. To collect relevant research materials, the study systematically retrieved information from authoritative databases such as CNKI, PubMed, Elsevier, Web of Science, and SpringerLink, employing keywords including “cultivation,” “phytochemistry,” “pharmacology,” and the plant names “Aucklandia lappa Decne.,” “Saussurea costus (Falc.) Lipsch.,” or “Aucklandiae Radix.” Despite demonstrating remarkable pharmacological activities and potential for clinical applications, research on ALD still faces several challenges. For instance, its specific mechanisms of action in treating certain diseases remain incompletely understood, and multiple studies have indicated that ALD extracts may cause adverse reactions. Further in-depth research and systematic evaluation can facilitate the optimization of ALD practices to promote further research into its myriad applications.
1 Introduction
Aucklandia lappa Decne. (ALD), synonym of Saussurea costus (Falc.) Lipsch., is a perennial herb belonging to the Asteraceae family that possesses a rich medicinal history extending over two millennia (Huang et al., 2021; Song et al., 2021). Currently, ALD is predominantly cultivated in the Yunnan, Guizhou, Guangxi and Sichuan provinces of China (Xue et al., 2020). Aucklandiae Radix (AR), commonly known as Muxiang or Yunmuxiang (Chinese trade name), is derived from the dried root of ALD. It has been utilized extensively as a medicinal material in traditional Chinese medicine (TCM) and is officially recognized in the Chinese Pharmacopoeia (Huang et al., 2021; Shum et al., 2007). Since 2014, when related industrial bases were established in Yunnan and Guizhou Province and Chongqing of China, large-scale planting was carried out based on the growth characteristics of ALD, and its economic benefits have achieved a leapfrog growth. In 2021, the national sales volume of ALD was approximately 6,000 tons, and by 2024, the national sales volume of ALD exceeded 8,300 tons.
The pharmacological effects of AR are diverse and significant (Li S.-Y. et al., 2024). Modern pharmacological researches have demonstrated that AR exhibits several properties, including the promotion of gastrointestinal motility, dilation of bronchial smooth muscles, antibacterial activity, reduction of blood glucose levels, and antitumor effects (Song et al., 2022b; Zhang et al., 2021; Zheng et al., 2022; Zhuang et al., 2021). The chemical composition of AR is complex and diverse, primarily encompassing terpenoids, glycosides, and other metabolites (anthraquinones, flavonoids, amino acids, etc.). Costunolide and dehydrocostus lactone are principal active metabolites in AR (Huang Z. et al., 2022). The total content of costunolide (PubChem CID 5281437, C15H20O2) and dehydrocostus lactone (PubChem CID 73174, C15H18O2) in AR must not be less than 1.8%, as stipulated by the Chinese Pharmacopoeia (2020 Edition). Concurrently, the European Union’s Traditional Herbal Medicinal Products Directive has officially recognized AR as a certified herbal preparation for the treating functional dyspepsia.
This review provides a comprehensive examination of the biological characteristics, cultivation techniques, chemical composition, traditional Chinese medicinal applications, pharmacological activities, and processing methods associated with ALD (Figure 1). Large-scale cultivation and standardized production, circular economy model innovation, and the development of bio-synthesized active substances along with alternative pathways can facilitate the optimization of ALD practices to promote further research into its diverse applications.
FIGURE 1
2 Botanical characteristics
ALD is a perennial, tall herb characterized by a thick main root with a distinctive aroma. The basal leaves are triangular-ovate, featuring pinnately lobed upper long petioles and shallowly lobed margins. The stem leaves are also triangular-ovate or ovate, with the base extending downward and being sessile or having winged petioles. ALD produces capitula with multiple outer bracts, and its flowers are bisexual, dark purple, tubular, with inferior ovaries. The flowering period occurs from July to August, followed by a fruiting period from August to September (Chen, 2025). ALD thrives in cool to cold climates and exhibits significant cold resistance, making it particularly suitable for high-altitude regions with relatively low temperatures and high humidity. This species is a deep-rooted plant, with roots extending 30–50 cm or even deeper into the soil.
3 Cultivation and management
The cultivation of ALD plays a decisive role in determining the quality of its medicinal material. This influence is primarily reflected in four key aspects: geo-authenticity, growing environment, cultivation management, and harvesting and processing practices. Firstly, the specific altitude, climate, and soil conditions in geo-authentic regions promote the accumulation of higher levels of active metabolites (such as costunolide and dehydrocostus lactone) in the plant. In contrast, non-authentic producing areas typically yield inferior medicinal efficacy. Secondly, scientific cultivation management is central to quality assurance. The use of high-quality seeds, emphasis on well-rotted organic fertilizers, crop rotation, and integrated green pest management ensure healthy plant growth without pesticide residues. Conversely, excessive use of chemical fertilizers and pesticides compromises quality and introduces safety risks. Finally, timely harvesting and standardized post-harvest processing are crucial for preserving the therapeutic potency and aromatic properties. Harvesting too early or too late, or using high-temperature drying methods, can lead to the loss of volatile oils and significantly diminish efficacy. Therefore, standardized management throughout the entire process, is essential for producing ALD that is safe, effective, and of high quality.
3.1 Cultivation techniques
When selecting a cultivation site for ALD, it is imperative to ensure that the slope faces east or north and the slope is maintained at 30°–35°. A shaded slope is preferable. Additionally, the soil should be loose, fertile and possess a deep profile, with loam or sandy loam enriched with humus being optimal, as this composition facilitates effective drainage. Low-lying areas, which are susceptible to flooding and consequently to root rot, should be avoided. For newly developed land, it is essential to thoroughly clear all the weeds and existing vegetation from the wasteland, incorporating these materials into the soil through deep plowing. Deep plowing should be carried out again in the following spring. In addition, cultivators may opt to grow wood-scented plants on land that has previously supported crops such as potatoes and corn (Chen, 2025). Given that ALD can accumulate harmful metals from its native soil, consumption of low-quality ALD may lead to the accumulation of toxic metal elements in the human body (Meng et al., 2021). Inductively coupled plasma mass spectrometry (ICPMS) provides a precise and reliable method for monitoring and controlling contamination levels in the extract, such as Cu, Pb, As, Cd, and Hg in ALD (Chen et al., 2023). The soil used for planting should effectively control the pollution of related metals. The arbuscular mycorrhizal fungi strains (Gigaspora decipiens, Scutellospora calospora, Racocetra coralloidea, Septoglomus deserticola, Entrophospora colombiana, Paraglomus brasilianum), which had a good symbiotic relationship with ALD, are the potential strains to inoculate ALD seedlings under artificial cultivation conditions (Yang et al., 2020). Symbiotic bacteria can significantly increase terpenoids accumulation (costunolide, dehydrocostus lactone, etc.), soluble protein, soluble sugar, antioxidant enzyme activity in the leaves.
3.2 Reproductive methods
Seed propagation serves as the primary method for the cultivation of ALD. In Yunnan Province, the cultivation of ALD predominantly involves seeds sowing, which can be conducted during the winter, autumn, and spring. Typically, spring sowing occurs from mid-March to early April, autumn sowing from late August to mid-September, and winter sowing in early November. Post-harvest, the seeds must be sun-dried and subsequently cleaned of impurities to prepare them for subsequent processes. Prior to sowing, it is essential to prepare the seeds by soaking them in lukewarm water with continuous stirring. As the water cools, impurities and non-viable seeds are removed, leaving only the viable seeds that settle at the bottom. These viable seeds are then soaked for 24 h before being partially dried in preparation for sowing.
If the seeds quantity is insufficient for planting requirements, asexual reproduction can be considered. It is crucial to avoid using fine roots with medicinal value as breeding material. During planting, the layout should be carried out according to the prescribed spacing. And when covering the soil, it is necessary to ensure that the root systems are completely and tightly buried. ALD propagation via cuttings requires a healthy selection of semi-hardened stems with 2–3 nodes. Stems are trimmed to retain 2–3 leaves for photosynthesis, followed by treatment with rooting hormones or basal soaking in diluted rooting agent for 30 min prior to air-drying. A sterile, well-draining substrate (e.g., a mixture of leaf mould and perlite) is prepared and sterilized to minimize pathogen risk. Processed cuttings are inserted into the substrate at a depth of 1/3–1/2 the stem length. Post-insertion, the medium is moderately watered to maintain moisture without waterlogging. Environmental conditions are maintained at 20 °C–25 °C with indirect light and adequate airflow to avoid direct sunlight exposure. Rooting initiates within 3–4 weeks, accompanied by new shoot development.
Large-scale planting has been carried out based on the growth characteristics of ALD in Yunnan and Guizhou Province and Chongqing of China. This large-scale planting is still mainly based on traditional agricultural cultivation methods. In the future, the yield, quality and production efficiency of ALD can be improved through multi-disciplinary means such as micropropagation and tissue culture technology, molecular biology, intelligent equipment and environmental control. Micropropagation and tissue culture technology represent a fundamental advancement in contemporary crop cultivation (; Lu et al., 2019). By employing asexual reproduction and cellular engineering techniques, these methods effectively address the challenges of low efficiency and genetic instability inherent in traditional seed propagation (Pupilli and Barcaccia, 2012). The root tips of ALD serve as highly differentiated potential explants suitable for plant tissue culture. By precisely regulating the growth system through genetic modification and improving stress resistance and the targeted accumulation of metabolites, the production efficiency and product value of ALD can be significantly enhanced. The precise regulation of nutrient solutions during the cultivation process can now be easily implemented (Lu et al., 2022; Wang et al., 2023). The demand for elements such as nitrogen, phosphorus, potassium, and calcium varies significantly at different stages of plant growth. Through dynamic monitoring and intelligent intervention, the accumulation of secondary metabolites, stress resistance, and growth consistency of medicinal plants like ALD may be significantly improved. Furthermore, based on historical data, a growth prediction model for ALD can be constructed, integrating environmental variables (temperature, precipitation, soil EC value) to output the best irrigation and fertilization decisions. If synthetic biology and intelligent equipment can be effectively combined, the ALD industry is expected to become a benchmark model in the global medicinal plant field.
3.3 Control of pests and diseases
Leaf spot disease and root rot represent significant threats to the growth cycle of ALD, particularly during the rainy season when the prevalence of these diseases increases markedly, with July and August identified as peak periods. To mitigate these challenges, growers should prioritize land with superior drainage and a lower groundwater table for cultivating ALD. During field management, it is crucial to handle the plants carefully to prevent root injury and to rigorously implement quarantine measures to ensure that seeds are free from pathogens. Once infected plants are identified, they should be immediately removed, and the soil should be disinfected with quicklime to curb the further spread of root rot (Tan et al., 2023). In cases where ALD seedlings exhibit symptoms of root rot, growers need to take prompt action by precisely spraying an appropriate amount of thiophanate-methyl or carbendazim on the roots of the affected plants (Gaitnieks et al., 2016). Additionally, during the rainy season, the application of Bordeaux mixture on clear days is advised to effectively prevent leaf spot disease. Upon noticing symptoms of disease on ALD seedlings, an appropriate amount of bactericides (tebuconazole or chlorothalonil) should be evenly sprayed on the leaves, with attention to rotating different pesticides to enhance control effectiveness.
The primary pests impacting ALD include grasshoppers, aphids, cutworms, and grubs. During their nymphal stage, grasshoppers can be effectively managed by spraying with a solution of 90% crystalline trichlorfon diluted to 800 times (Zhang et al., 2019). Aphids can be controlled by spraying with a solution of 40% dimethoate emulsifiable concentrate diluted 800 to 1,500 times (Chandrasena et al., 2011). Cutworms and grubs, which damage seedlings, roots, and leaves, can be effectively trapped and eradicated using bait made by combining crystalline trichlorfon with wheat bran (Kumar and Pandey, 2022; Smirle et al., 2013).
4 Ethnopharmacology
The earliest documentation of AR appears in the ancient book “Supplements to the Shennong Bencao by Medical Masters” (《名医别录》). Subsequently, classical works such as “The Newly Revised Materia Medica” (《新修本草》), “Illustrated Classic of Materia Medica” (《本草图经》), “Essential Documents of the Tang Dynasty” (《唐会要》), “Muslim Medicine” (《回回药方》), and “Compendium of Materia Medica” (《本草纲目》) have systematically recorded its applications, underscoring its integration into both Chinese pharmacology and cross-cultural medical traditions. In the Qing Dynasty, the “Essential Compendium of Materia Medica” (《本草备要》) systematically standardized the processing techniques of ALD, establishing protocols that balanced traditional practices with empirical refinement. At present, it is officially recognized in the Chinese Pharmacopoeia (《中国药典》2020 Edition).
4.1 Identification of AR
AR originates from the dried root of ALD, which is collected during the autumn and winter seasons. Once dried, the coarse outer skin is removed. The final product is typically cylindrical or semi-cylindrical, measuring between 5 and 10 cm in length and 0.5–5 cm in diameter. Its surface boasts a yellowish-brown to grayish-brown coloration, adorned with prominent wrinkles, longitudinal grooves, and lateral root marks. The texture is notably firm, making it resistant to breaking. Upon sectioning, the interior reveals a grayish-brown to dark-brown coloration, with a grayish-yellow or light brownish-yellow periphery. A distinct brown cambium ring is evident, accompanied by a radial texture. It possesses a unique aroma and a slightly bitter taste (China Pharmacopoeia Committee, 2020a).
4.2 Traditional uses of AR
Four traditional AR-based prescriptions have been recorded in the Chinese Pharmacopoeia (2020 edition): Muxiang Fenqi Wan (China Pharmacopoeia Committee, 2020e), Muxiang Shunqi Wan (; China Pharmacopoeia Committee, 2020f), Muxiang Binglang Wan (China Pharmacopoeia Committee, 2020d; Gao et al., 2024), and Liuwei Muxiang San (China Pharmacopoeia Committee, 2020c). These traditional medicines primarily treat gastrointestinal stagnation, abdominal distension pain, and bowel obstruction.
Additionally, other traditional prescriptions that were not included in the Chinese Pharmacopoeia have also been studied (Table 1). Simo Decoction has been shown to enhance gastrointestinal motility by influencing the contractions of antral circular smooth muscle strips (Dai et al., 2012). JianPi’I, which originates from the classical Chinese medicine formula Xiangshaliujunzi decoction, is known to alleviate symptoms associated with postprandial distress syndrome (Wang et al., 2016). The Xian-He-Cao-Chang-Yan formula has been demonstrated to ameliorate DSS-induced colitis in mice (Li J. et al., 2021). Weichang’an Pill has been widely used for decades in the treatment of irritable bowel syndrome and functional dyspepsia (Zhang et al., 2013). Kangen-karyu (GuanYuan-Ke-Li) is considered a promising therapeutic agent for Alzheimer’s disease (Paudel et al., 2020). Xianglian Pill, composed of Rhizoma coptidis and AR, has long been employed in the management of gastrointestinal disorders (Lu et al., 2020). Clinically, Wuwei Shexiang Pill is used in China to reduce joint pain and swelling, as well as to dispel wind and alleviate pain (). Additionally, treatment with Muxiang gel plaster has been found to effectively prevent and mitigate mammary hyperplasia (Wu Y. et al., 2024).
TABLE 1
| Name | Formula (except for AR) | Indications | Ref. |
|---|---|---|---|
| Muxiang Fenqi Wan | Wurfbainia compacta, Syzygium aromaticum L. , Santalum album, Cyperus rotundus L., Pogostemon cablin, Citrus reticulata Blanco, Magnolia officinalis, Citrus aurantium L., Curcuma longa L., Crataegus monogyna Jacq., Atractylodes macrocephala Koidz., Nardostachys jatamansi, Areca catechu L., Glycyrrhiza glabra L. | Bloating, abdominal pain | China Pharmacopoeia Committee (2020e) |
| Muxiang Shunqi Wan | Wurfbainia compacta, Cyperus rotundus L., Areca catechu L., Glycyrrhiza glabra L., Magnolia officinalis, Citrus aurantium L., Atractylodes Lancea, Citrus reticulata Blanco, Zingiber officinale Roscoe | Bloating, abdominal pain | (; China Pharmacopoeia Committee, 2020f) |
| Muxiang Binglang Wan | Areca catechu L., Citrus aurantium L., Citrus reticulata Blanco, Cyperus rotundus L., Sparganium emersum Rehmann, Curcuma longa L., Coptis chinensis Franch., Cortex Phellodendri Chinensis, Rheum officinale Baill., Semen Pharbitidis, Natrii Sulfas | Bloating, abdominal pain, uncomfortable bowel movements | (China Pharmacopoeia Committee, 2020d; Gao et al., 2024) |
| Liuwei Muxiang San (Wan) | Gardenia jasminoides, Punica Granatum, Rhododendron molle, Wurfbainia compacta Rotundus, Piper longum L. | Bloating, abdominal pain, uncomfortable bowel movements | (China Pharmacopoeia Committee, 2020c; Renqing-Dongzhu et al., 2023) |
| Simo decoction | Citrus aurantium L., Areca catechu L., Lindera aggregata (Sims) Kosterm. | Gastrointestinal dysmotility | (Dai et al., 2012; Yi et al., 2011) |
| JianPi'I | Codonopsis pilosula (Franch.) Nannf., Atractylodes macrocephala Koidz., Poria cocos, Wurfbainia compacta, Glycyrrhiza glabra L., Citrus reticulata Blanco, Pinellia ternata (Thunb.) Makino | Postprandial distress syndrome | Wang et al. (2016) |
| Xian-He-Cao-Chang-Yan formula | Agrimonia eupatoria L., Coptis chinensis Franch., Cyperus esculentus L., Acorus verus (L.) Raf., Platycodon grandiflorus Jacq. | Colitis | Li et al. (2021a) |
| Weichang’an Pill | Lignum Aquilariae Resinatum, Lignum Aantali Albi, Citrus aurantium L., Cortex Magnoliae officinalis, Rheum officinale Baill., Conioselinum anthriscoides, Croton tiglium L., Ziziphus jujuba Mill., Abelmoschus moschatus Medik. | Irritable bowel syndrome and functional dyspepsia | Zhang et al. (2013) |
| Kangen-karyu (GuanYuan-Ke-Li) | Salvia miltiorrhiza Bunge, Conioselinum anthriscoides, Paeonia lactiflora Pall., Carthamus tinctorius L., Cyperus rotundus L. | Alzheimer’s disease | Paudel et al. (2020) |
| Xianglian pill | Coptis chinensis Franch. | Gastrointestinal disease | Lu et al. (2020) |
| Wuwei Shexiang pills | Terminalia chebula Retz., Abelmoschus moschatus Medik., Aconitum carmichaelii Debx., Acorus calamus L. | Joint pain | |
| Muxiang gel plaster (Muxiang Bing) | Edible gelatin, Rehmannia glutinosa (Gaertn.) Libosch., catalpol, rehmannioside D, tartaric acid, carbomer, sodium polyacrylate, dihydroxyaluminium aminoacetate, glycerol | Mammary hyperplasia | Wu et al. (2024b) |
| Anshen-Buxin-Liuwei pill | Bos taurus domesticus Gmelin, Choerospondias axillaris, Myristica fragrans Houtt., Eugenia caryophμllata Thunb., Liquidambar formosana | Cardiomyocyte hypoxia/reoxygenation injury | Huang et al. (2022a) |
List of TCM prescriptions related to ALD.
With the development of TCM, the active metabolites in medicinal substances can be concentrated, extracted and combined to enhance their therapeutic efficacy. A metabolite formulation, consisting of three herbal extracts (CO2 supercritical fluid extract of ginger, ethanol reflux extract of AR, and pogostemonis herba essential oil) has been developed as a promising anti-motion sickness treatment (Zhang et al., 2015).
4.3 Traditional processing
The traditional processing techniques for ALD involves several methods aimed at enhancing its efficacy and adaptability for various Chinese medicinal formulations (Li X. et al., 2021; Song et al., 2022a). These methods include the use of raw AR, stir-fried AR, baked (or grilled) AR, and wine-processed AR. Raw AR denotes the cleaned and dried form of the original medicinal material, which undergoes impurity removal, washing, slicing, and drying. Stir-fried AR is prepared by lightly frying the slices with bran before they are used in formulations. Baked AR, also known as grilled AR, involves stir-frying the pieces with bran until they turn yellow, after which they are cooled and incorporated into medicinal applications (Wu M.-l. et al., 2024). Wine-processed AR is made by moistening the botanical drug with rice wine, followed by slicing and drying for medicinal use.
These traditional processing techniques for the botanical drug AR significantly influence the quality and therapeutic direction of the final product by carefully controlling the heating intensity and the use of auxiliary materials: raw AR retains abundant volatile oils, offering strong medicinal properties but also greater side effects due to alkaloids and other metabolites; roasting gently heats the botanical drug at low temperatures, promoting the release or transformation of some volatile oils, thereby reducing side effects and mildly enhancing its gastrointestinal therapeutic functions; plain stir-frying and bran-frying reduce toxicity and adverse effects while strengthening its therapeutic efficacy; wine-processing using rice wine facilitates the extraction of active metabolites, increasing pharmacological activity. Essentially, these methods work by regulating the content and transformation of volatile oils and other metabolites to achieve reduced toxicity, preserved efficacy, enhanced potency, or altered therapeutic targeting (Feng et al., 2023; Li R.-l. et al., 2021).
4.4 Adverse reaction (toxicity)
Although AR has good medicinal value, excessive use may lead to adverse effects. Skin allergic reaction is a common side effect in the use of AR, due to various irritant alkaloids (saussureanine, costunolide, etc.), for people who are sensitive or have existing skin inflammation, contact with these substances is easy to cause allergic reactions. Acute generalized exanthematous pustulosis also could induced by AR (Chu et al., 2019). Additionally, high doses of TCM usually have liver toxicity, and AR is no exception. Oxidative stress should be the primary mechanism for the high-dose AR-induced hepatotoxicity, and Nrf2, HO-1 and NQO1 were the main targets (Song et al., 2024). On the contrary, the appropriate dosage of ethanol extract of AR had a protective effect on liver injury induced by lipopolysaccharide in rats (Song et al., 2023). Reasonable control of the dosage of AR is important for patients to avoid side effects, which can effectively ensure the safety and effectiveness of Chinese herbal medicine.
4.5 Commonly confused botanical drugs
In the field of traditional botanical drugs, species within the AR, Aristolochiae Radix (ARR), Vladimiriae Radix (VR), and Inulae Radix (IR), present persistent identification challenges due to morphological convergence and historical misclassification (Zhuang et al., 2021). These taxonomically related species exhibit overlapping botanical characteristics, particularly in root morphology and histological features, resulting in frequent substitution errors in herbal commerce. Current pharmacognostic authentication relies on UHPLC-QTOF-MS as the gold-standard methodology for precise differentiation (Guccione et al., 2017; Shum et al., 2007; Wang et al., 2024). This analytical approach enables simultaneous detection of multiple marker metabolites, achieving clear discrimination between structurally analogous aristolochic acid derivatives and sesquiterpene lactone.
VR (“Chuanmuxiang” in China), primarily derived from the dried roots of Vladimiria souliei (Franch.) Ling or V. souliei (Franch.) Lingvar. cinerea Ling, predominantly cultivated in western Sichuan, China, exhibits medicinal properties akin to those of Muxiang, albeit with distinct emphases (China Pharmacopoeia Committee, 2020b). Chemical profiling differentiates AR from VR based on significant differences in their quantitative composition (dihydrodehydrocostus lactone, mokkolactone, α-costol, etc.) (Chen et al., 2020; Liang et al., 2024; Yan et al., 2020). The total lactone extract of VR has the similar protective effects on cholestatic liver injury as AR, even better in terms of anti-inflammatory properties (Chen Z. et al., 2022).
IR (“Tumuxiang” in China) refers to the dried roots of Inula helenium L. or Inula racemosa Hook.f. (China Pharmacopoeia Committee, 2020g). Historically utilized as a substitute for AR, IR exhibits significant chemical distinctions from AR, with its primary differential metabolites being alantolactone and isoalantolactone (; Rasul et al., 2013). These metabolites have been used to emesis and diarrhoea, and to eliminate parasites (Xu et al., 2015). Alantolactone and isoalantolactone have been confirmed to possess potential hepatotoxicity, nephrotoxicity, and allergenic effects. Long-term or excessive intake may lead to symptoms such as loss of appetite, fatigue, nausea, vomiting, and pain in the liver area. In severe cases, it can cause irreversible liver damage. Due to their toxicity, IR has been rarely used in modern clinical practice of TCM.
ARR (“Qingmuxiang” in China) is the dried roots of Aristolochia debilis Sieb. et Zucc. or Aristolochia contorta Bge. ARR originally appeared as a substitute for AR, but contemporary researches have revealed the presence of aristolochic acid in Aristolochiae species, which can cause nephrotoxic adverse reactions (Cheng et al., 2006; Wang X. et al., 2020; Zhang et al., 2016). Consequently, ARR has been banned from use in TCM formulations (Luo et al., 2024).
In summary, careful identification of AR’s species authenticity and quality is essential during procurement and use to prevent confusion with commonly confused botanical drugs. At the same time, it is recommended to use AR and its related botanical drugs under the guidance of a professional physician or pharmacist.
4.6 Botanical drugs with similar therapeutic properties
The commercially available herbal medicines exhibiting comparable qi-regulating, analgesic, spleen-strengthening, and digestion-promoting activities to AR primarily include Pericarpium Citri Reticulatae, Aurantii Fructus, Cyperi Rhizoma, and Amomi Fructus. However, their therapeutic emphases and clinical applications exhibit notably divergent profiles. Additionally, AR demonstrates multidimensional industrial advantages over other botanical drugs in its category.
Specifically, the flavonoid metabolites (hesperidin, nobiletin, tangeretin, etc.) in Pericarpium Citri Reticulatae are susceptible to rapid degradation under UV light, resulting in poor stability (Ho and Kuo, 2014; Li Y. et al., 2024). Aurantii Fructus contains alkaloids such as p-tyramine, N-methyltyramine, and tyramine that may cause cardiovascular adverse reactions including hypertension and arrhythmia, thus requiring careful evaluation of the patient’s baseline condition in clinical use (Gao et al., 2020). Cyperus volatile oils, rich in α-cyperone, cyperotundone, and limonene, face industrial scalability challenges due to low extraction yields (). Amomi Fructus is constrained by its reliance on specific cultivation conditions and high production costs (Suo et al., 2018). In contrast, AR not only has a mild nature and comprehensive effects, but also stands out in terms of the stability of its metabolites, safety, and the maturity of industrialization. Therefore, it is more suitable for large-scale pharmaceutical production, food processing, and the development of health products.
5 Phytochemistry
Currently, more than 200 metabolites (Table 2) have been isolated and identified from ALD (Huang et al., 2021; Zheng et al., 2022). These metabolites can be categorized by structural type into sesquiterpene lactones (eudesmanolides, guaianolides, germacranolides, etc.), monoterpenoids, triterpenoids, phenylpropanoids, steroids, flavonoids, amino acids, and other metabolites (Huang et al., 2021; Seo et al., 2015; Wang Y. et al., 2020; Zheng et al., 2022). These metabolites were primarily isolated and identified using techniques such as thin-layer chromatography (TLC), nuclear magnetic resonance (NMR), liquid chromatography (LC), gas chromatography (GC), mass spectrometry (MS), and electronic nose (e-nose) technology.
TABLE 2
| Number | Classification | Molecular formula | Metabolites |
|---|---|---|---|
| 1 | Sesquiterpene lactones - eudesmanolides | C15H20O2 | α-Cyclocostunolide |
| 2 | C15H20O3 | Santamarine | |
| 3 | C15H22O3 | 11α,13-Dihydrosantamarine | |
| 4 | C15H20O2 | β-Cyclocostunolide | |
| 5 | C15H20O3 | Reynosin | |
| 6 | C15H22O3 | 11α,13-Dihydroreynosin | |
| 7 | C15H20O3 | Magnolialide | |
| 8 | C15H22O3 | 11α,13-Dihydromagnolialide | |
| 9 | C15H22O3 | Arbusculin A | |
| 10 | C15H22O4 | 1β-Hydroxyarbusculin A | |
| 11 | C15H20O2 | Arbusculin B | |
| 12 | C15H24O3 | Colartin | |
| 13 | C15H20O4 | 1β-Hydroxycolartin | |
| 14 | C15H20O2 | Alantolactone | |
| 15 | C15H20O2 | Isoalantolactone | |
| 16 | C15H20O3 | Saussureal | |
| 17 | C15H22O2 | Dihydro-α-cyclocostunolide | |
| 18 | C20H28NO5 | Saussureamine D | |
| 19 | C20H28NO5 | Saussureamine E | |
| 20 | C16H22O6S | 13-Sulfo-dihydrosantamarine | |
| 21 | C16H22O6S | 13-Sulfo-dihydroreynosin | |
| 22 | Sesquiterpene lactones - guaianolides | C15H18O2 | Dehydrocostus lactone |
| 23 | C15H20O2 | Dihydrodehydrocostus lactone | |
| 24 | C15H20O3 | 4β-Methoxy-dehydrocostuslactone | |
| 25 | C15H20O3 | 4α-Methoxy-dehydrocostuslactone | |
| 26 | C15H20O3 | 10α-Methoxy-dehydrocostuslactone | |
| 27 | C15H18O3 | 11,13-Epoxy-dehydrocostuslactone | |
| 28 | C15H16O4 | 11,13-Epoxy-3-keto-dehydrocostuslactone | |
| 29 | C15H20O2 | Mokko lactone | |
| 30 | C16H22O3 | 13-Methoxy-dihydrodehydrocostuslactone | |
| 31 | C17H22O4 | Lappalone | |
| 32 | C15H18O3 | Zaluzanin C | |
| 33 | C17H20O4 | Zaluzanin D | |
| 34 | C21H30O8 | 11β,13-Dihydroglucozalunin C | |
| 35 | C15H18O3 | Isozaluzanin C | |
| 36 | C15H20O3 | 11β,13-dihydro-3-epizaluzanin C | |
| 37 | C15H18O4 | 11,13-Epoxyisozaluzanin C | |
| 38 | C15H18O2 | Isodehydrocostuslactone | |
| 39 | C15H16O3 | Isodehydrocostuslactone-15-aldehyde | |
| 40 | C15H16O3 | Isodehydrocostuslactone-14β- aldehyde | |
| 41 | C20H26NO4 | Saussureamine B | |
| 42 | C19H24NO5 | Saussureamine C | |
| 43 | C15H20O5S | Sulfocostunolide A | |
| 44 | C18H20O6 | Cynaropicrin | |
| 45 | C15H20O5S | Sulfocostunolide B | |
| 46 | C21H28O8 | 3-O-β-D-Glucopyranoside-1α,3α,5α,7αH-guaiane-10(14),11 (13)-trien-6α,12-olide | |
| 47 | Sesquiterpene lactones - germacranolides | C15H20O2 | Costunolide |
| 48 | C15H22O2 | 11α,13-Dihydrocostunolide | |
| 49 | C15H22O2 | 11β,13-Dihydrocostunolide | |
| 50 | C16H24O3 | 13-Methoxydihydrocostunolide | |
| 51 | C20H28NO4 | Saussureamine A | |
| 52 | C21H30O8 | Picriside B | |
| 53 | C15H22O2 | Isodihydrocostunolide | |
| 54 | C15H20O3 | Soulangianolide A | |
| 55 | C15H20O3 | Parthenolide | |
| 56 | C20H26O6 | Eupatoriopicrin | |
| 57 | C15H22O2 | Saussurea lactone | |
| 58 | C20H30O8 | Saussurea lactone-10-O-β-D-glucoside | |
| 59 | C15H20O2 | Dehydrosaussurea lactone | |
| 60 | C30H38O6 | Lappadilactone | |
| 61 | Other sesquiterpenoids | C15H24 | α-Selinene |
| 62 | C15H24 | β-Selinene | |
| 63 | C15H24 | γ-Selinene | |
| 64 | C15H24O | α-Costol | |
| 65 | C15H24O | β-Costol | |
| 66 | C15H24O | γ-Costol | |
| 67 | C15H22O | α-Costal | |
| 68 | C15H22O | β-Costal | |
| 69 | C15H22O | γ-Costal | |
| 70 | C15H22O2 | Costic acid | |
| 71 | C15H22O2 | Isocostic acid | |
| 72 | C15H26O2 | 4β-Hydroxy-11 (13)-eudesmane-12-al | |
| 73 | C15H24O2 | Ilicol | |
| 74 | C15H22O3 | 5α-Hydroxy-costic acid | |
| 75 | C15H26O | γ-Eudesmol | |
| 76 | C15H26O | α-Eudesmol | |
| 77 | C15H26O | β-Eudesmol | |
| 78 | C15H24 | γ-Muurolene | |
| 79 | C15H24 | Eudesma-3,7 (11)-diene | |
| 80 | C17H26O4 | 1β,6α-Dihydroxycostic acid ethyl ester | |
| 81 | C15H24 | β-Maaliene | |
| 82 | C15H24 | (+)-Germacrene | |
| 83 | C15H24O | Germacra-1(10),4,11(13)-tiren-12-ol | |
| 84 | C15H22O | Germacra-1(10),4,11(13)-tiren-12-al | |
| 85 | C15H22O2 | Germacra-1(10),4,11(13)-tiren-12-oic acid | |
| 86 | C15H24 | β-Elemene | |
| 87 | C15H24O | Elema-1,3,1 (13)-tiren-12-ol | |
| 88 | C15H22O | Elemenal | |
| 89 | C15H28O | Elemol | |
| 90 | C15H24 | α-Humulene | |
| 91 | C15H24 | β-Humulene | |
| 92 | C15H24 | β-Caryophyllene | |
| 93 | C15H24O | Epoxy-caryophyllene | |
| 94 | C15H24 | α-Cedrene | |
| 95 | C15H24 | β-Cedrene | |
| 96 | C15H24O | Cedrenol | |
| 97 | C15H24 | α-Bergamotene | |
| 98 | C15H22O | 2,12-Bergamotadien-14-al | |
| 99 | C14H24O | (E)-9-Isopropyl-6-methyl-5,9-decadien-2-one | |
| 100 | C15H20 | α-Calacorene | |
| 101 | C15H22 | α-Curcumene | |
| 102 | C15H24 | γ-Curcumene | |
| 103 | C15H24 | α-Zingiberene | |
| 104 | C15H24 | Valencene | |
| 105 | C15H24 | β-Sesquiphellandrene | |
| 106 | C15H24O | Glaucyl alcohol | |
| 107 | C15H24 | β-Bergamotene | |
| 108 | C15H24 | Longifolene | |
| 109 | C15H24 | γ-Gurjunene | |
| 110 | C15H24 | α-Gurjunene | |
| 111 | C15H24 | Bisabolene | |
| 112 | C15H24 | cis-α-Bisabolene | |
| 113 | C15H30O | Nerolidol | |
| 114 | C15H26O | Viridiflorol | |
| 115 | C15H26O | Globulol | |
| 116 | C15H26O | Ledol | |
| 117 | C15H24 | α-Longipinene | |
| 118 | C15H24 | β-Guaiene | |
| 119 | C15H24 | α-Guaiene | |
| 120 | C15H22O | Santalol | |
| 121 | C15H24O | Aromadendrene epoxide | |
| 122 | C15H24 | trans-β-Farnesene | |
| 123 | C15H24 | α-Farnesene | |
| 124 | C15H24 | β-Himachalene | |
| 125 | C15H26O | Hedycaryol | |
| 126 | C15H24 | Aromadendrene | |
| 127 | C15H22O | Nootkatone | |
| 128 | C15H24O | Thujopsanone | |
| 129 | C15H24O | trans-α-Bergamotol | |
| 130 | C15H24O | Santalcamphor | |
| 131 | C15H24O | Longifolenaldehyde | |
| 132 | C15H24O | Spathulenol | |
| 133 | C15H24 | α-Copaene | |
| 134 | C15H24 | α-Bulnesene | |
| 135 | C15H26O | Valerianol | |
| 136 | C15H28O2 | Cryptomeridiol | |
| 137 | Monoterpenoids | C15H24O | γ-Gurjunenepoxide-(2) |
| 138 | C10H16 | Camphene | |
| 139 | C10H16 | Phellandrene | |
| 140 | C13H20O | α-Ionone | |
| 141 | C13H20O | β-Ionone | |
| 142 | C13H22O | 3,4-Dihydro-α-ionone | |
| 143 | C13H20O2 | (3R,6S)-α-Ionone-3-ol | |
| 144 | C13H17O2 | α-Ionone-4-one | |
| 145 | C13H20O2 | (3R,6R)-α-Ionone-3-ol | |
| 146 | C10H16 | Myrcene | |
| 147 | C10H18O | Linalool | |
| 148 | C10H16 | α-Terpinene | |
| 149 | C10H16 | β-Terpinene | |
| 150 | C10H18O | Isoborneol | |
| 151 | C10H18O | Borneol | |
| 152 | C10H16 | γ-Terpinene | |
| 153 | C10H16 | α-Pinene | |
| 154 | C10H16 | β-Pinene | |
| 155 | C10H18O | 4-Terpineol | |
| 156 | C10H18O | α-Terpineol | |
| 157 | C13H22O | α-Ionol | |
| 158 | C10H16 | Limonene | |
| 159 | C10H16 | Terpinolene | |
| 160 | C13H22O | Geranylacetone | |
| 161 | C10H20O | Menthol | |
| 162 | C10H16O | Carvotanacetone | |
| 163 | C12H22O2 | Linalyl acetate | |
| 164 | C10H18O | Menthone | |
| 165 | C10H16O | (+)-Camphor | |
| 166 | Triterpenoids | C30H50O | α-Amyrin |
| 167 | C34H58O2 | 3β-Acetyl-9 (11)-baccharene | |
| 168 | C30H48O3 | Betulinic acid | |
| 169 | C30H50O2 | Betulinol | |
| 170 | C31H50O3 | Betulinic acid methyl ester | |
| 171 | C30H50O | Taraxsterol | |
| 172 | C30H50O | 3-Filicanone | |
| 173 | Phenylpropanoids | C17H24O9 | Syringin |
| 174 | C16H22O8 | 4-Allyl-2,6-dimethoxyphenolglucoside | |
| 175 | C16H18O9 | Chlorogenic acid | |
| 176 | C10H12O | Anethole | |
| 177 | C12H14O3 | Eugenol acetate | |
| 178 | C9H8O | Cinnamaldehyde | |
| 179 | C10H10O2 | Safrole | |
| 180 | C10H12O | Estragole/4-Allylanisole | |
| 181 | C12H8O4 | Bergapten | |
| 182 | C13H14O4 | 6,8-Dimethoxy-3,7-dimethylisocoumarin | |
| 183 | C26H32O12 | 1-Hydroxyrosinol-1-O-β-D-glucopyranoside | |
| 184 | C26H34O13 | (−)-olivil-4″-O-β-D-glucopyranoside | |
| 185 | C22H26O8 | Syringaresinol | |
| 186 | C20H22O8 | Prinsepiol | |
| 187 | C29H36O11 | (+) -1-Hydroxypinoresinol-4″-O-methyl ester-4′-β-D-glucopyranoside | |
| 188 | C28H34O10 | (+)-1-Hypinoresinol-4″-O-β-D-glucopyranoside | |
| 189 | Steroids | C30H46O6 | Lappalanasterol |
| 190 | C31H50O | 3-Epi-lappasterol | |
| 191 | C21H32O2 | Pregnenolone | |
| 192 | C35H60O6 | Daucosterol | |
| 193 | C29H50O | β-Sitosterol | |
| 194 | C29H48O | Stigmasterol | |
| 195 | C28H48O | Campesterol | |
| 196 | C29H50O | γ-Sitosterol | |
| 197 | Flavonoids | C29H48O2 | Vlasoudiol |
| 198 | C46H60O22 | 3’-(3 R-Acetoxy-5,5-dimethylcyclopent-1-ene)-4′-Omethylscutellarein-7-O-(6‴’-Oacetyl-β-D-glucopyranosyl-(1 → 3)-[α-L-rhamnopyranosyl-(1 → 2)]-β-D-glucopyranoside | |
| 199 | C44H58O21 | Kaempferol-3-O-β-Dglucopyransoyl-(1 → 4)-α-Lrhamnopyranosyl-(1 → 6)-β-D-galactopyranoside 7-O-(6‴’O-acetyl-β-Dglucopyranosyl-(1 → 3)-[α-L-rhamnopyranosyl (1 → 2)]-β-D-glucopyranoside | |
| 200 | C47H54O20 | Kaempferol-3-O-β-Dglucopyranosyl (1 → 2)-β-D-(6a′-Ocaffeoyl)-glucopyranoside 7-O-(6‴ ’-O-acetyl-β-Dglucopyranosyl-(1 → 3)-[α-L-rhamno-pyranosyl-(1 → 2)]β-D-glucopyranoside | |
| 201 | C49H48O15 | Kaempferol-3-O-α-L-(2a′,3a′-E-di-p-coumaroyl)-rhamnoside 7-O-(6‴’-O-acetyl-β-Dglucopyranosyl-(1 → 3)-[α-Lrhamnopyranosyl-(1 → 2)]-β-D-glucopyranoside | |
| 202 | C10H10O4 | 5,7-Dihydroxy-2-methylchromone | |
| 203 | C16H14O7 | 1-Hydroxy-2,3,4,7-tetramethoxyxanthone | |
| 204 | C15H12O6 | 1,7-Dihydroxy-3,4-dimethoxyxanthon | |
| 205 | Amino acid | C2H5NO2 | Aspartic acid |
| 206 | C4H7NO4 | Glycine | |
| 207 | C4H8N2O3 | L-Asparagine | |
| 208 | C4H9NO2 | 4-Aminobutyric acid | |
| 209 | C4H9NO3 | L-Threonine | |
| 210 | C3H7NO3 | Serine | |
| 211 | C5H9NO4 | Glutamic acid | |
| 212 | C5H10N2O3 | Glutamine | |
| 213 | C3H7NO2 | Alanine | |
| 214 | C6H13N3O3 | Citrulline | |
| 215 | C5H11NO2 | Valine | |
| 216 | C6H12N2O4S2 | Cystine | |
| 217 | C6H13NO2 | Isoleucine | |
| 218 | C6H13NO2 | Leucine | |
| 219 | C9H11NO3 | Tyrosine | |
| 220 | C9H11NO2 | Phenylalanine | |
| 221 | C5H12N2O2 | Ornithine | |
| 222 | C6H14N2O2 | Lysine | |
| 223 | C6H9N3O2 | Histidine | |
| 224 | C6H14N4O2 | Arginine | |
| 225 | C21H20O10 | Aloe-emodin-8-O-β-D-glucopyranoside | |
| 226 | C21H18O11 | Rhein-8-O-β-D-glucopyranoside | |
| 227 | C15H10O4 | Chrysophanic acid | |
| 228 | C10H20O6 | N-Butyl-β-D-fructoside | |
| 229 | C7H14O6 | Methyl-α-D-frutofuranoside | |
| 230 | C12H16O6 | Phenyl-β-D-glucopyranoside | |
| 231 | C13H18O6 | Benzyl-β-D-glucopyranoside | |
| 232 | C19H32O8 | Ascleposide E | |
| 233 | C19H12O8 | β-D-Frutofuranose | |
| 234 | C6H12O6 | Glucose | |
| 235 | C8H8O3 | Vanillin | |
| 236 | C6H6O3 | 5-Hydroxymethyl-furaldehyde | |
| 237 | C9H10O4 | 3,5-dimethoxy-4-hydroxy-benzaldehyde | |
| 238 | C21H38O4 | Monolinolein | |
| 239 | C4H6O4 | Succinic acid | |
| 240 | C17H32O | Shikokiol A | |
| 241 | C17H32O | Shikokiol B | |
| 242 | C17H32O | Shikokiol C | |
| 243 | C7H6O2 | p-Hydroxybenzaldehyde | |
| 244 | C9H10O4 | 3,5-Dimethoxy-4-hydroxyacetophenone | |
| 245 | C16H32O2 | Palmitic acid | |
| 246 | C10H14 | p-Cymene | |
| 247 | C19H34O2 | (Z, Z)-9,12-Octadecadienoic acid | |
| 248 | C21H38O4 | (Z, Z)-9,12-Octadecadienoic acid-2-hydroxy-1,3propamedinyl ester |
Main metabolites isolated from AR (Zheng et al., 2022; Zhuang et al., 2021).
5.1 Sesquiterpene lactones
The sesquiterpene lactones are the primary and characteristic metabolites of ALD, exhibiting a diverse and abundant range exceeding 130 species (Yuan et al., 2024; Zheng et al., 2022). Sesquiterpene lactones are a class of natural metabolites primarily found in plants of the Asteraceae family, characterized by a 15-carbon sesquiterpenoid backbone coupled with a lactone ring (; Liu et al., 2021). They often serve as defensive metabolites in plants and are largely responsible for their characteristic bitter taste. These metabolites are renowned for their diverse and potent biological activities, including anti-inflammatory, anti-tumor, antimicrobial, and immunomodulatory effects (). As a result, they represent not only key active metabolites in traditional herbal medicine but also important lead metabolites in modern drug development. However, their bioactivity is dual-edged: some members are strong allergens capable of inducing contact dermatitis and may exhibit cytotoxicity at higher concentrations (da Silva et al., 2021).
Among the sesquiterpene lactones, costunolide and dehydrocostus lactone are the key substances for quality control of AR (Figure 2) (Dong et al., 2018). The total content of costunolide and dehydrocostus lactone in AR must not be less than 1.8%, as stipulated by the Chinese Pharmacopoeia (2020 Edition). They are also the most important active substances in AR and could be quantified synchronously using high-performance liquid chromatography coupled with mass spectrometry (Seo and Shin, 2015; Zhang et al., 2014). Currently, costunolide is already available in substantial quantities through genetic engineering techniques. The biosynthetic pathway for costunolide (Figure 3) has been successfully built in Escherichia coli by the co-expression of three genes (GAS, GAO, COS) involved in costunolide biosynthesis, along with eight genes responsible for converting acetyl-CoA into farnesyl diphosphate via the mevalonate pathway. And costunolide yield was up to 100 mg L−1 in E. coli (Yin et al., 2015). Meanwhile, the co-expression of GAS, GAO, and COS in yeast and Nicotiana benthamiana leaves has also facilitated costunolide production (). Revealing the synthetic pathway of costunolide indicates that there are no obstacles at all in constructing transgenic plants of ALD that produce high yields of costunolide. However, despite the structural similarities between dehydrocostus lactone and costunolide, and their concurrent presence in plants, the biosynthetic pathway for dehydrocostus lactone in plants remains unidentified. Consequently, the production of dehydrocostus lactone still relies on the extraction from plant raw materials.
FIGURE 2
FIGURE 3
5.2 Monoterpenoids and triterpenoids
Monoterpenoids and triterpenoids are two important classes of natural terpenoid metabolites, each with distinct characteristics in structure, distribution, and function (Yang et al., 2025). Monoterpenoids, composed of two isoprene units (C10), are major metabolites of plant essential oils (; Jiang and Wang, 2023). In contrast, triterpenoids consist of six isoprene units (C30), featuring higher molecular weight and greater structural complexity (Huang et al., 2024; Zeng et al., 2024). Monoterpenoids and triterpenoids are widely used in the flavor, food, and cosmetics industries. Their biological effects tend to be more profound and systemic, including notable anti-inflammatory, antitumor, immunomodulatory, and cholesterol-lowering activities (Yang et al., 2025). Representative metabolites such as α-amyrin and betulinic acid are core active metabolites in many traditional Chinese medicines. However, some triterpenoids may exhibit hepatotoxicity at high doses.
5.3 Phenylpropanoids
Phenylpropanoids are an important class of plant secondary metabolites characterized by a fundamental C6–C3 skeleton, which consists of a benzene ring (C6) attached to a propene group (C3), also known as the phenylpropane backbone (Vogt, 2010). These metabolites are primarily synthesized through the shikimate pathway and play crucial roles in plant defense, growth development, and signal transduction (; Zhang et al., 2025). Additionally, they serve as significant sources for numerous pharmaceuticals, flavoring agents, and industrial raw materials.
5.4 Steroids
Steroids represent a significant class of bioactive metabolites in TCM. Phytosterols (β-sitosterol, lappalanasterol, pregnenolone, etc.) are the predominant type in ALD. Structurally, phytosterols resemble cholesterol in animals, sharing the same cyclopentanoperhydrophenanthrene core skeleton, but differ in their side chain configurations. These steroidal metabolites exhibit diverse structures and broad biological functions, serving not only as a fundamental chemical basis for explaining the efficacy and mechanisms of TCM, but also as key resources for modern drug (steroid hormones) development (Ferreira-Guerra et al., 2020).
5.5 Flavonoids
Flavonoids are ubiquitous in traditional Chinese medicine and are one of the key metabolites that enable many medicinal materials to exert their therapeutic effects. Flavonoids are distinguished by their broad spectrum of biological activities, including antioxidant effects, cardiovascular protection, and antiplatelet aggregation, which collectively contribute to reducing the risk of cardiovascular diseases and enhancing blood circulation (Jomova et al., 2025; Xu et al., 2025).
5.6 Others
In addition to the previously mentioned metabolites, ALD has been identified to contain polysaccharides, higher fatty acids, small aliphatic alcohols, aldehydes, acids, amino acids, and cholamine, among other metabolites (Peng et al., 2025; Zhuang et al., 2021). The presence of these metabolites in AR may provide a pharmacological basis for the utilization of this herbal medicine in the treatment of constipation, intestinal infections, and associated inflammatory diseases. Higher fatty acids, amino acids, and cholamine are essential for maintaining normal physiological functions of the body (Chen and Fang, 2025; Kelling et al., 2024; Wu et al., 2022). Meanwhile, although the specific mechanisms of action of aliphatic alcohols, aldehydes, and acids require further investigation, they may play significant roles in regulating metabolism and participating in immune responses.
6 Pharmacology
The pharmacological effects of AR are diverse and significant (Table 3).
TABLE 3
| Pharmacological activities | Main findings | References |
|---|---|---|
| Antioxidant | The preadministration of ALD extract exerted its protective effect of Th-induced adult male rats mainly through potentiating the antioxidant defense system by decreased lipid peroxidation and NO and increase the glutathione content. | |
| The aqueous solvents of ALD were found superior in their ability to extract the antioxidants and aqueous ethanol was reported more efficient than aqueous methanol. | ||
| Alcoholic extract of AR (including alkaloids, terpenoid, phenols and others) have comparable antioxidant activity to ascorbic acid (81.96%). | ||
| The extract of ALD showed high levels of total phenolic content (188.2 ± 2.1 mg GAE/g DM) and total flavonoid content (129 ± 2.6 mg QE/g DM). In antioxidant tests, the extract exhibited strong activity, with the IC50 values of 137.15 μg/mL for ABTS and 175.5 μg/mL for DPPH. | ||
| α,β-Unsaturated carbonyl metabolites (costunolide, dehydrocostus lactone, artemisitene, santamarine, isoalantolactone) were mainly featured as the antioxidant active metabolites of AR. | Wu et al. (2025) | |
| The 70% ethanol extract of ALD has a higher concentration of total phenolic content, total flavonoids, and antioxidant effect than the 70% methanol and water extracts. Rats pretreated with ALD extracts (70% methanol, 300 mg/kg BW) reduced the harmful effects induced by NaNO2 and improved the hematological parameters, liver, and kidney function biomarkers as well as lipid profile as compared to the NaNO2 group (75 mg/kg BW, single oral dose for 4 weeks). | Elshaer et al. (2022) | |
| Anti-inflammatory | Dehydrocostuslactone exerts potent anti-hepatocellular carcinoma effects by inducing ER stress-mediated apoptosis via the MAPK pathway, resulting in a 50% reduction in tumor volume in vivo after 45 days of treatment. | Hsu et al. (2009) |
| AR alleviates ulcerative colitis by targeting PKM2 to inhibit the NF-κB and NLRP3 pathways, thereby reducing inflammation and modulating immune responses. | Feng et al. (2024) | |
| Dehydrocostus lactone alleviates irinotecan (CPT-11)-induced intestinal mucositis by inhibiting the TLR4/MD2 complex and suppressing the NF-κB/NLRP3 signaling pathway, without compromising the antitumor efficacy of CPT-11. | Sun et al. (2024) | |
| The sesquiterpene lactone-rich fraction of ALD alleviates ulcerative colitis by regulating the Nrf2-Hmox-1, NF-κB, and MAPK pathways. | Chen et al. (2022a) | |
| ALD demonstrates potential in preventing and treating benign prostatic hyperplasia (BPH) by modulating apoptosis and inflammation, as evidenced by reduced prostate weight, improved apoptotic protein expression, and decreased inflammatory cytokines in a testosterone-induced BPH rat model. | Choi et al. (2021) | |
| The combined topical application of ALD and Thuja orientalis extracts demonstrates synergistic efficacy in alleviating atopic dermatitis symptoms by reducing pro-inflammatory activity and immune hyperresponsiveness, outperforming either extract alone. | Yang et al. (2017) | |
| α,β-Unsaturated carbonyl metabolites are as the key anti-inflammatory and antioxidant metabolites in ALD. | Wu et al. (2025) | |
| The sesquiterpenoids isolated from ALD, exhibit significant anti-inflammatory activity by inhibiting NO production in LPS-stimulated macrophages at 20 μM. | Lyu et al. (2023) | |
| In a DSS-induced murine ulcerative colitis UC model, daily gavage with dehydrocostus lactone at 20, 15, and 10 mg/kg/d from day 4–17 significantly reduced inflammation and enhanced barrier function by suppressing the IL-6/STAT3 pathway. | Zhou et al. (2020) | |
| Dehydrocostus lactone alleviates atherosclerosis by promoting cholesterol efflux and inhibiting inflammation via the TLR2/PPAR-γ/NF-κB signaling pathway in both in vivo and in vitro models. | Hong et al. (2025) | |
| Alantolactone exerts anti-inflammatory effects in LPS-stimulated macrophages by suppressing NF-κB activation and MAPK phosphorylation via downregulation of the MyD88-dependent signaling pathway. | Chun et al. (2012) | |
| Owing to the multi-target nature of IBD, the natural formulation KM1608 demonstrates potential therapeutic value by ameliorating colitis symptoms and distributing effectively in the intestinal tract. | Lee et al. (2020) | |
| Epoxymicheliolide alleviates ulcerative colitis by covalently targeting TAK1 and Keap1 to inhibit NF-κB-mediated inflammation and activate the Nrf2 antioxidant pathway. | He et al. (2022) | |
| Dehydrocostus lactone significantly ameliorated DSS-induced colitis in mice at doses of 5–15 mg/kg by covalently targeting both IKKα/β and Keap1, thereby suppressing NF-κB signaling and activating the Nrf2 pathway. | Yuan et al. (2022) | |
| ALD demonstrates potential as a therapeutic agent for osteoarthritis by exhibiting analgesic and anti-inflammatory effects in both in vivo and in vitro models. | Jo et al. (2021) | |
| The ethanol extract of ALD demonstrates anti-inflammatory effects by suppressing NF-κB and MAPK pathways and antioxidant activity through activation of the Nrf2/HO-1 pathway in LPS-stimulated RAW 264.7 cells. | Lim et al. (2020) | |
| Anti-cancer effect | For the ethyl acetate extract of AR (including arbusculin B, α-cyclocostunolide, costunolide, and dehydrocostus lactone), cytotoxic ICSOS of rat skeletal myoblast (L6 cells) from were from 1.6 to 19 μM, and selectivity indices from 0.5 to 6.5. | Julianti et al. (2011) |
| The supercritical fluid extraction of oils from ALD obtained at 10 MPa exhibited the strongest antitumor efficacy with IC50 values of approximately 0.44, 0.46, and 0.74 μg/mL on HCT, MCF-7, and HepG-2 cells, respectively, whereas those at 20 MPa showed higher IC50 values (2.33, 6.59, 19.0 μg/mL), followed by 48 MPa (36.02, 59.5, 96.9 μg/mL). | ||
| Lyophilized ALD selectively inhibits the growth of breast and cervical cancer cells by inducing alternative apoptotic pathways. | Hasson et al. (2018) | |
| AR extract demonstrated significant antiproliferative and apoptotic effects, inducing caspase-3/7 and annexin V/PI activity, on MCF-7 breast cancer cells at concentrations of 20–200 μg/mL over 24–72 h, supporting its potential as a low-toxicity therapeutic candidate. | Kumar et al. (2024b) | |
| Stigmasterol, isoboldine, and β-sitosterol could target key prostate cancer-related hub genes (e.g., SRC, FGFR1, HSP90AA1); stigmasterol showed the strongest binding to HSP90AA1, and pathway analysis highlighted involvement of PI3K/AKT signaling. | Kosanam et al. (2024) | |
| A study on 72 mice with PVP-induced cancer demonstrated that AR extract exhibited anticancer effects by reducing cell proliferation and modulating liver enzyme levels (ALT: 29.01 ± 1.8, AST: 87.55 ± 2.9, ALP: 98.12 ± 8.8 U/L in controls), with dose-dependent tissue regeneration observed across treatment groups. | ||
| AR extract at 500 mg/kg body weight demonstrated the highest anti-neoplastic efficacy in a DMBA-induced rat mammary tumour model, significantly reducing tumour progression, oxidative stress, pro-inflammatory cytokines (TNF-α and NF-κB), and expression of Ki-67, MMP-9, and VEGF markers. | Kumar et al. (2024a) | |
| AR extracts and isolated sesquiterpene lactones (particularly isoalantolactone, alantolactone, β-cyclocostunolide, and α-cyclocostunolide) exhibited significant cytotoxicity against A549 and C-6 cancer cells. | Kumar et al. (2014) | |
| The hexane and chloroform fractions of ALD exhibited potent anticancer activity against the PC-3 prostate cancer cell line, with IC50 values of 3.37 ± 0.14 μg/mL and 7.53 ± 0.18 μg/mL, respectively. | ||
| ALD extracts demonstrated potent anticancer activity by inducing G1 phase arrest and intrinsic apoptosis via the mitochondrial pathway in breast, liver, and colon cancer cells, with IC50 values as low as 0.25–2.5 μg/mL for the most active extracts. | Shati et al. (2020) | |
| Three new eudesmane-type sesquiterpene lactone galactosides, costunosides A–C, were isolated from ALD and identified as the first natural β-galactopyranoside-containing eudesmane glycosides, among which metabolite 3 exhibited cytotoxic activity against several human cancer cell lines with IC50 values ranging from 3.4 to 9.3 µM. | ||
| Dehydrocostus lactone demonstrates anti-angiogenic activity by inducing G0/G1 cell cycle arrest via inhibition of the Akt/GSK-3β/cyclin D1 and mTOR pathways, as evidenced in both in vitro and nude mice models. | ||
| Dehydrocostus lactone from ALD inhibits viability, migration, and proliferation of laryngeal carcinoma cells (Hep-2 and TU212) with low toxicity to normal HBE cells, and suppresses tumor growth in vivo by inducing mitochondrial apoptosis via inhibiting PI3K/Akt/Bad and activating ER stress pathways. | Zhang et al. (2020) | |
| Organ protection | AR extract improved lung injury by reducing iNOS, caspase-3, and microRNA-let-7a, while boosting HO-1. | |
| Anti-diabetic effect | Two proteinaceous amylase inhibitors, ScAI-R (IC50 = 23 μg/mL, Ki = 0.38 µM) and ScAI-L (IC50 = 28 μg/mL, Ki = 0.32 µM), which were from ALD, displayed the high affinities towards human salivary and pancreatic α-amylases (up to 90% inhibitory activity). | |
| The administration of extracts of ALD into Streptozotocin-treated rats separately resulted in a decline in the elevated levels of blood glucose, total cholesterol, triglycerides and improving serum HDL-Cholesterol and body weight. | Gomaa et al. (2021) | |
| All streptozotocin-treated diabetic rats received the treatments of ALD- extracts (200–400 mg/kg bwt., with isochlorogenic acid A (8393.64 μg/g) and chlorogenic acid (6,532.65 μg/g)) orally for 21 days consecutively, the administration significantly mitigated diabetic hyperglycemia. | ||
| The casein encapsulated extract of ALD demonstrated anti-diabetic potential through inhibition of α-amylase and α-glucosidase activities and enhanced glucose uptake in HepG2 cells. | Mushtaq et al. (2025) | |
| Antiparasitic effect | The ethyl acetate extract of AR (including arbusculin B, α-cyclocostunolide, costunolide, and dehydrocostus lactone) potently inhibited the growth of Trypanosoma brucei rhodesiense, with ICsos between 0.8 and 22 μM. | Julianti et al. (2011) |
| Trichinella spiralis experimental infection induced DNA damage and oxidative stress in rat skeletal muscles and treatments with AR extract modulates these changes. | ||
| In vitro, extract of AR showed a significant anthelmintic effect on live adult Ascaridia.galli worms in terms of inhibition of worm motility, with worm motility inhibition of 100% at 24 h post-exposure at the 100 mg/mL. | Mir et al. (2024) | |
| Antimicrobial effect | The highest activity with the lowest MIC value was recorded as 3.12 μL/mL for the essential oil of ALD (against S. epidermidis and C. albicans), 3.12 mg/mL for the methanolic extract (against S. aureus), and 6.25 mg/mL for both hexane-chloroform and aqueous extracts (against S. aureus). | |
| The smoke of ALD successfully inhibited P. crustosum growth of Fresh walnuts. | Qiao et al. (2023) | |
| Ethanol extracts of AR had inhibitory effects on common plant-pathogenic fungi, with EC50 (concentration for 50% of maximal effect) values ranging from 114.18 mg/L to 414.08 mg/L. | ||
| The highest minimum inhibitory concentration was seen in the ethanolic extract of ALD, with an MIC of 50 mg/mL for S. aureus followed by an MIC of 200 mg/mL for K. pneumoniae. It showed a MBC against S. aureus and K. pneumoniae (>50 mg/mL and >200 mg/mL, respectively). | (Mammate et al., 2023; Mishra et al., 2020) | |
| The acetic acid extract of ALD exhibited significant antimicrobial activity (in vitro) against C. albicans (MIC = 6.25 mg/mL, MFC = 12.5 mg/mL), followed by B. cereus, S. enterica, S. aureus, E. coli, and P. aeruginosa, respectively (MIC = 25 mg/mL, MBC/MFC = 25–50 mg/mL). | Idriss et al. (2023) | |
| The inhibitory activity of all ALD extracts at three different extraction pressure levels (10, 20, 48 MPa), was higher than gentamicin against all tested bacteria (B. subtilis, and S. aureus, P. aeruginosa, E. coli, K. pneumonia, C. albicans, C. tropicalis, A. flavus, F. oxysporium). | ||
| Antiviral effect | The antiviral activity of ALD acetic acid extract had a significant positive influence against HSV-1 (EC50 = 82.6 g/mL; CC50 = 162.9 g/mL; selectivity index = 1.9). No effect was detected in terms of the inhibition of SARS-CoV2 entry. | Idriss et al. (2023) |
| Some sesquiterpenoids isolated from ALD demonstrate anti-HBV activity by inhibiting HBsAg secretion. | Li et al. (2024a) | |
| The value of the in vitro IC50 of AR extract against low pathogenic human coronavirus (HCoV-229E) and human influenza virus (H1N1) influenza virus were 23.21 ± 1.1 and 47.6 ± 2.3 μg/mL, respectively. | ||
| The ALD phytoconstituents have inhibitory potential against the receptor-binding domain of the spike glycoprotein and the main protease of the SARS-CoV-2 Delta (B.1.617.2) variant of the novel coronavirus via molecular docking, DFT, and ADME/Tox studies. | Houchi and Messasma (2022) | |
| The bioactive molecules from ALD can be as SARS-CoV-2 main protease inhibitors by computational approach investigation. | Hajji et al. (2022) |
The main pharmacological properties of ALD.
6.1 Antioxidant
The antioxidant profile of ALD multifaceted, stemming from its rich and diverse phytochemical composition. The high values for total phenolic (188.2 ± 2.1 mg GAE/g DM) and flavonoid (129 ± 2.6 mg QE/g DM) content are paramount (). Phenolics and flavonoids are renowned antioxidants due to their hydrogen-donating ability, which neutralizes free radicals by stabilizing them. The in vitro assays (DPPH and ABTS) confirm this radical-scavenging capability. The IC50 values (137.15 μg/mL for ABTS, 175.5 μg/mL for DPPH) represent the concentration required to scavenge 50% of the radicals (). Lower IC50 values indicate higher potency. The extract of AR have comparable antioxidant activity to ascorbic acid (). α,β-Unsaturated carbonyl metabolites (costunolide, dehydrocostus lactone, artemisitene, santamarine, isoalantolactone) were mainly featured as the antioxidant active metabolites of AR (Wu et al., 2025). This molecular structure is a key pharmacophore for antioxidant activity. It can quench free radicals through direct single-electron transfer. Ultimately, the most significant evidence of its antioxidant power is its in vivo protective effect against NaNO2-induced toxicity. NaNO2 is a potent oxidant that causes methemoglobinemia and oxidative damage to organs. The extract’s ability to improve hematological parameters and protect liver and kidney function biomarkers demonstrates that its antioxidants are bioavailable and active within a living system, effectively mitigating systemic oxidative stress (Elshaer et al., 2022). This bridges the gap from laboratory findings to potential therapeutic applications, suggesting ALD could be developed into a natural remedy for conditions where oxidative stress is a key pathological factor.
6.2 Anti-inflammatory
The extract of ALD and its isolated bioactive metabolites, particularly sesquiterpene lactones such as dehydrocostus lactone, alantolactone, and epoxymicheliolide, demonstrate significant anti-inflammatory activity across multiple experimental models. In LPS-stimulated RAW 264.7 macrophages and peritoneal macrophages, ALD and these metabolites consistently suppress the production of key proinflammatory mediators, including NO, PGE2, iNOS, COX-2, and the cytokines IL-6, IL-1β, and TNF-α (He et al., 2022; Lim et al., 2020). This broad inhibition of inflammatory outputs is not limited to macrophage models but extends to in vivo conditions such as osteoarthritis (Jo et al., 2021), where ALD reduces pain and serum IL-1β, and to inflammatory bowel disease (IBD) models (Lee et al., 2020), including dextran sulfate sodium (DSS)-induced colitis (Yuan et al., 2022), where it ameliorates symptoms, protects the colonic barrier, and lowers inflammatory cytokines and enzymes like myeloperoxidase (MPO).
The fundamental mechanism underlying this robust anti-inflammatory effect involves the dual suppression of the NF-κB and MAPK signaling pathways (Figure 4) (Lim et al., 2020). ALD and its metabolites inhibit the LPS-induced phosphorylation and degradation of IκBα, thereby preventing the nuclear translocation of the NF-κB subunits p65 and p50 (Chun et al., 2012; Lim et al., 2020). Concurrently, these metabolites inhibit the phosphorylation of MAPKs, including JNK, ERK, and p38 (Chun et al., 2012; Hsu et al., 2009; Lim et al., 2020). Further upstream, alantolactone was shown to suppress the expression of adaptor proteins MyD88 and TIRAP, which are critical for initiating these cascades (Chun et al., 2012). Importantly, this anti-inflammatory activity is complemented by a potent antioxidative effect mediated through the activation of the Nrf2/HO-1 pathway. Metabolites like dehydrocostus lactone and epoxymicheliolide enhance the nuclear accumulation of Nrf2, leading to the upregulation of antioxidant genes and a reduction in intracellular ROS (Yuan et al., 2022). Mechanistic studies reveal that many of these actions depend on the presence of an α,β-unsaturated carbonyl group, which allows the metabolites to form covalent bonds with key cysteine residues on target proteins like IKKα/β, Keap1, or TAK1 (He et al., 2022; Wu et al., 2025; Yuan et al., 2022).
FIGURE 4
The therapeutic implications of these mechanisms are vast, as evidenced by efficacy in diverse inflammatory disease models. Beyond colitis and osteoarthritis, ALD and dehydrocostus lactone alleviate atherosclerosis by promoting cholesterol efflux in macrophage-derived foam cells and modulating the TLR2/PPAR-γ/NF-κB pathway (Hong et al., 2025). They also show protective effects against irinotecan-induced intestinal mucositis by inhibiting the TLR4/NF-κB/NLRP3 axis and against benign prostatic hyperplasia by restoring apoptosis balance (Choi et al., 2021; Sun et al., 2024). Furthermore, a sesquiterpene lactone-rich fraction of ALD was significantly more effective than an aqueous extract in treating ulcerative colitis (Chen Y. et al., 2022), underscoring that these specific metabolites are the primary active anti-inflammatory agents. This multifaceted, multitargeted action, targeting both inflammation and oxidative stress, positions ALD and its metabolites as promising candidates for treating complex chronic inflammatory disorders.
6.3 Anti-cancer effect
The supercritical fluid extraction of oils from ALD demonstrates remarkable and concentration-dependent cytotoxic efficacy against various cancer cell lines. Specifically, the extract obtained at 10 MPa exhibited potent antitumor activity with IC50 values of approximately 0.44, 0.46, and 0.74 μg/mL against HCT-116, MCF-7, and HepG-2 cells, respectively, whereas extracts obtained at higher pressures (20 MPa and 48 MPa) showed significantly reduced potency, highlighting the critical influence of extraction parameters on bioactive metabolite efficacy (). Furthermore, specific sesquiterpene lactones like costunolide, dehydrocostus lactone, alantolactone, and isoalantolactone, isolated from the roots, have demonstrated significant activity against diverse cancer types including lung (A549), glioma (C-6), and prostate (PC-3) cancer cells, with hexane and chloroform fractions of ALD showing particularly low IC50 values, such as 3.37 ± 0.14 and 7.53 ± 0.18 μg/mL against PC-3 cells, respectively (; Kumar et al., 2014).
The anticancer mechanisms of these extracts and metabolites are primarily mediated through the induction of apoptosis via both intrinsic and extrinsic pathways. Lyophilized ALD significantly suppressed the growth and proliferation of T-47D and HeLa cells by inducing apoptosis, as evidenced by suppressed LDH release, reduced NO production, and activation of death receptors in a dose-dependent manner (Hasson et al., 2018). Similarly, ALD extract promoted apoptosis in MCF-7 cells by activating caspase-3/7 and annexin V/PI pathways (Kumar et al., 2024b). In-depth mechanistic studies on dehydrocostus lactone have revealed its ability to inhibit angiogenesis by inducing G0/G1 cell cycle arrest in human umbilical vein endothelial cells (HUVECs) through the abrogation of the Akt/GSK-3β/cyclin D1 and mTOR signaling pathways (). Moreover, in laryngeal carcinoma cells, dehydrocostus lactone induced mitochondrial apoptosis by inhibiting the PI3K/Akt/Bad pathway and stimulating endoplasmic reticulum stress-mediated apoptosis, accompanied by the upregulation of p53 and P21 (Zhang et al., 2020).
In vivo studies substantiate the anticancer potential and reduced systemic toxicity of these natural metabolites. In a 12-dimethylbenz (a) anthracene (DMBA)-induced mammary tumour model in rats, treatment with ALD root extract at 500 mg/kg body weight resulted in significant chemopreventive effects, demonstrated by inhibition of tumour parameters, minimal alterations in liver and kidney enzymes, reduction in oxidative stress, decreased pro-inflammatory cytokines (TNF-α and NF-κB), and downregulation of proliferation (Ki-67), metastasis (MMP-9), and angiogenesis (VEGF) markers (Kumar et al., 2024a). Another study in mice induced with cancer using Polyvinyl pyrrolidone K-30 (PVP) showed that ethanolic extract of ALD reduced cancer cell proliferation and mitigated histopathological damage in the liver and kidneys in a dose-dependent manner, contrasting with the severe damage observed in chemotherapy-treated groups (). Furthermore, molecular docking and virtual screening studies identified bioactive metabolites in ALD, such as stigmasterol, isoboldine, and beta-sitosterol, with favourable ADME (Absorption, Distribution, Metabolism, and Excretion) and toxicity profiles, showing strong binding affinities to hub genes like SRC, FGFR1, and HSP90AA1 involved in prostate cancer pathways, particularly PI3K/AKT signaling (Figure 5) (Kosanam et al., 2024). This multi-targeted approach, combined with a favourable safety profile, positions ALD and its bioactive metabolites as promising candidates for further development as anticancer therapeutics.
FIGURE 5
6.4 Organ protection
AR extract demonstrates significant organ-protective effects, particularly against acute lung injury, through a multi-target and multi-pathway mechanism. The study revealed that AR extract ameliorates cyclophosphamide-induced histological damage in the lung by concurrently modulating inflammatory, oxidative, and apoptotic pathways (). Specifically, its protective action is mediated through the reduction of iNOS and the caspase-3, which attenuates excessive inflammation and inhibits programmed cell death, respectively. Furthermore, AR extract alleviates oxidative stress by significantly decreasing the level of MDA, a marker of lipid peroxidation, while upregulating the gene expression of the HO-1. The accompanying downregulation of microRNA-let-7a suggests a potential involvement in epigenetic regulation, though its precise role requires further elucidation. This evidence collectively indicates that AR extract’s organoprotective efficacy is achieved via a synergistic combination of anti-inflammatory, antioxidant, and anti-apoptotic activities.
6.5 Anti-diabetic effect
ALD exhibits multi-faceted anti-diabetic properties, demonstrated through both in vitro and in vivo studies. Two novel non-competitive proteinaceous inhibitors, ScAI-R (IC50 = 23 μg/mL, Kᵢ = 0.38 µM) and ScAI-L (IC50 = 28 μg/mL, Kᵢ = 0.32 µM), purified from the roots and leaves, showed high affinity towards human salivary and pancreatic α-amylases, achieving up to 90% inhibitory activity (). Further supporting these findings, the casein-encapsulated extract of bioactive metabolites from ALD significantly inhibited α-amylase and α-glucosidase activities and enhanced glucose uptake in HepG2 cells (Mushtaq et al., 2025). In diabetic rat models induced by Streptozotocin, oral administration of ALD extracts—containing high concentrations of phenolic metabolites such as dehydrocostus lactone, azulene, eicosapentaenoic acid, linoelaidic acid, isochlorogenic acid A, and chlorogenic acid resulted markedly reduced blood glucose, total cholesterol, and triglyceride levels, while improving HDL-cholesterol and body weight (; Gomaa et al., 2021). These results collectively highlight the potential of ALD a source of effective anti-diabetic agents through enzyme inhibition and metabolic regulation.
6.6 Antiparasitic effect
Based on multiple studies, the extract of ALD and its specific bioactive metabolites, such as costunolide and dehydrocostuslactone, demonstrate broad-spectrum antiparasitic properties by exhibiting both direct lethal effects and indirect host-protective mechanisms. The ethyl acetate extract of AR (including arbusculin B, α-cyclocostunolide, costunolide, and dehydrocostuslactone) potently inhibited the growth of Trypanosoma brucei rhodesiense, with ICsos between 0.8 and 22 μM (Julianti et al., 2011). In vitro, extract of AR showed a significant anthelmintic effects on live adult Ascaridia.galli worms in terms of inhibition of worm motility, with worm motility inhibition of 100% at 24 h post-exposure at the 100 mg/mL (Mir et al., 2024). Beyond direct parasite killing, research reveals a complementary protective role; in a Trichinella spiralis-infected rat model, the extract significantly modulated infection-induced DNA damage and oxidative stress in host tissues (). This collective evidence positions ALD as a highly promising source for novel antiparasitic agents, offering a dual mechanism of action that combines direct potency with alleviation of the pathological damage caused by parasitic infections.
6.7 Antimicrobial effect
The essential oil, hexane-chloroform, methanolic, and aqueous extracts of AR have been proven to have certain antimicrobial effects on Acinetobacter baumannii, Aspergillus flavus, Alternaria alternata, Bacillus cereus, Blumeria graminis, Botrytis cinerea, Candida tropicalis, Colletotrichum gloeosporioides, Candida albicans, Didymella glomerata, Escherichia coli, Enterobacter cloacae, Enterococcus faecalis, Fusarium oxysporum, Fusarium graminearum, Fusarium lateritium, Klebsiella pneumonia, Pseudomonas aeruginosa, Pythium aphanidermatum, Phytophthora infestans, Sclerotinia sclerotiorum, Salmonella enterica, Staphylococcus aureus, and Staphylococcus epidermidis (; ; ; Idriss et al., 2023). Meanwhile, the smoke of ALD successfully inhibited Penicillium crustosum growth of fresh walnuts (Qiao et al., 2023). The antimicrobial mechanism of the extract of AR is multi-targeted, mainly including: damaging the structure of the cell membrane, inhibiting the formation of biofilms, inhibiting quorum sensing and inducing the production of ROS. The composites of ALD demonstrated significantly stronger antimicrobial activity compared to its individual metabolites, causing clear structural damage to resistant strains, such as chitosan-AR nanoconjugates (), iron oxide nanoparticles of AR (), and AR-MgO nanoparticles (Mishra et al., 2020). AR extract is undoubtedly a natural antibacterial agent with great research and development value. Its broad-spectrum antibacterial activity, especially its effective effect on drug-resistant bacteria and biofilms, makes it a promising candidate for addressing the global antibiotic resistance crisis.
6.8 Antiviral effect
Studies have demonstrated the broad-spectrum antiviral potential of extracts and metabolites from ALD and related botanicals. Some lappanolides from ALD exhibits excellent anti-HBV activity (Li H.-B. et al., 2024). The value of the in vitro IC50 of AR extract against low pathogenic human coronavirus (HCoV-229E) and human influenza virus (H1N1) influenza virus were 23.21 ± 1.1 and 47.6 ± 2.3 μg/mL, respectively. (). The antiviral activity of ALD acetic acid extract had a significant positive influence against HSV-1 (EC50 = 82.6 g/mL; CC50 = 162.9 g/mL; selectivity index = 1.9) (Idriss et al., 2023).
The bioactive molecules from ALD can be as SARS-CoV-2 main protease inhibitors by computational approach investigation (Hajji et al., 2022). The ALD phytoconstituents have inhibitory potential against the receptor-binding domain of the spike glycoprotein and the main protease of the SARS-CoV-2 Delta (B.1.617.2) variant of the novel coronavirus using molecular docking, DFT, and ADME/Tox studies (Houchi and Messasma, 2022). However, in the actual experiment, no effect was still detected in terms of the inhibition of SARS-CoV2 entry (Idriss et al., 2023).
Currently, the vast majority of research on the antiviral effects of ALD (especially against SARS-CoV-2) remains at the stage of computer simulations (e.g., molecular docking) and in vitro studies. While these findings provide a solid theoretical foundation and valuable guidance for further investigation, there is still a long way to go before clinical application can be realized. Validation through animal studies and human clinical trials is still needed. It is also important to note that ALD a complex multi-metabolite system, and its antiviral activity likely results from the synergistic effects of various metabolites rather than a single metabolite. From a modern scientific perspective, its antiviral properties may be associated with holistic regulatory functions, such as anti-inflammatory and immunomodulatory effects.
7 Conclusion
In the-present review, we have-presented the biological characteristics, cultivation techniques, chemical composition, pharmacological activities, and processing techniques pertaining to ALD. ALD, as core metabolites in traditional Chinese herbal formulations for treating hepatic and intestinal inflammation, have drawn global attention for their therapeutic potential in biopharmaceutical applications. The future development of ALD-derived products must be propelled by technology-driven innovation and supported by institutional synergy. Through standardized systems to elevate industrial upgrading, regulatory science to dismantle market barriers, synthetic biology to redefine resource supply, and clinical research to unlock health potential, ALD-related industries are poised to emerge as global benchmarks in biopharmaceuticals and sustainable development. This transformation will not only alleviate global pressures on natural drug supply chains but also disseminate the wisdom of traditional Chinese medicine worldwide, advancing the modernization of traditional Chinese medicine into the global health governance framework.
8 Further perspectives
8.1 Limitations
Although ALD demonstrates significant medicinal potential, particularly its notable anticancer activity, there remain major limitations in current research that severely hinder its transition from a traditional remedy to a modern, internationally recognized drug.
First, the standardization of botanical drug sources and quality is the primary obstacle. The origin of ALD is complex, and variations in harvesting seasons and processing methods lead to significant differences in the types and concentrations of its internal chemical metabolites. Existing research has predominantly focused on exploring the activity of specific extracts or metabolites but lacks a comprehensive and systematic quality evaluation system for the botanical drug itself. Most studies rely only on individual active metabolites (such as costunolide and dehydrocostus lactone) as quality control indicators, which fails to comprehensively reflect the holistic nature of the botanical drug and its “multi-metabolite, multi-target” mechanism of action. This lack of standardization makes it difficult to reproduce, compare, and integrate research results from different laboratories, resulting in fragmented data that cannot provide a consistent and reliable material basis for clinical medication.
Secondly, research on the active metabolites and their mechanisms of action remains insufficient. Although numerous bioactive metabolites (costunolide, dehydrocostus lactone, alantolactone, etc.), have been isolated and identified, and their functions in inducing apoptosis and inhibiting angiogenesis have been confirmed, most studies remain at the stage of phenomenological observation and preliminary mechanistic exploration. The majority of mechanistic research relies on in vitro cell models, where the drug concentrations used are often significantly higher than the achievable levels in vivo, raising doubts about the extrapolation of the findings. There is a notable lack of research on how the multiple metabolites in ALD interact synergistically or antagonistically to produce therapeutic effects, which is an aspect central to the philosophy of traditional Chinese medicine. Furthermore, current studies focus predominantly on its anticancer properties, while modern scientific explanations of its traditional efficacy are severely lacking. Little effort has been made to integrate newly discovered functions (e.g., anti-inflammatory effects and regulation of gastrointestinal motility) with traditional knowledge.
Thirdly, the pharmacokinetic and safety evaluation systems require significant improvement. The processes of oral absorption, distribution, metabolism, and excretion of the main active metabolites in ALD, such as lactones, remain largely unclear. Key questions persist: What is their bioavailability? In what form do they exert effects in vivo, as parent metabolites or metabolites? What kind of pharmacokinetic interactions exist between these metabolites and commonly used chemotherapy drugs? All these questions remain unanswered. Although some studies suggest that its extracts exhibit low toxicity to normal cells, there is a lack of systematic toxicological studies that meet modern drug approval standards, including investigations into long-term toxicity, reproductive toxicity, and genotoxicity. The potential risk of “nephrotoxicity” has also been frequently mentioned, but solid experimental data to either confirm or refute this claim are still lacking. This uncertainty represents a major concern for its clinical adoption.
Finally, there is a significant lack of clinical research. Almost all encouraging data currently available come from preclinical studies (in vitro cell and animal experiments). There is a shortage of rigorously designed and standardized clinical trials to verify the actual efficacy and safety of these treatments in humans. In traditional Chinese clinical practice, ALD is most commonly used in formulations. However, modern research has rarely attempted to simulate such complex environments to explore its role and effects within these formulations. Moreover, the considerable gap between discovering highly active extracts or metabolites in the laboratory and developing them into quality-controlled, standardized preparations suitable for patient use remains largely unaddressed.
8.2 Future research needs
To promote the in-depth development of ALD research and facilitate its clinical translation, future work should focus on the following aspects to meet the needs of a comprehensive research pipeline from basic to applied studies.
Firstly, future research needs to focus on establishing a quality control methodology based on a “holistic perspective”. Modern chromatographic, spectroscopic, and coupling techniques (such as HPLC-MS and GC-MS) should be utilized, in combination with chemometric methods, to conduct systematic analysis of ALD from different sources. This will help establish a “fingerprint profiling” standard that covers multiple major active metabolites and characteristic metabolites. At the same time, active research on spectrum-effect relationships should be carried out to correlate chemical fingerprints with pharmacological efficacy data. This will help identify which groups of metabolites are the key material basis for specific pharmacological effects (such as anti-cancer, anti-inflammatory, and anti-ulcer activities).
Secondly, it is essential to employ multi-omics technologies (genomics, transcriptomics, proteomics, metabolomics) and systemic biological approaches to comprehensively and unbiasedly uncover the target sites and network pathways of ALD and its active metabolites. This represents a core requirement. Comprehensive clinical studies in line with international standards must be initiated. It is imperative to systematically complete pharmacokinetic studies on the main active metabolites and optimized extracts of ALD to clarify their ADME properties. Additionally, toxicological evaluations should be conducted to thoroughly assess the safety of long-term usage and fully elucidate potential risks such as nephrotoxicity.
Thirdly, innovative formulation technologies and translational research should be a top priority for future studies. Given that many lactone metabolites exhibit poor water solubility and low bioavailability, there is a need to develop novel drug delivery systems such as nanoparticles, liposomes, and phospholipid complexes, to enhance their targeting capability and therapeutic efficacy. Furthermore, these advanced systems can help mitigate systemic toxicity associated with non-selective drug exposure.
8.3 Priorities
Faced with numerous research demands, it is crucial to concentrate resources on addressing key issues. In the short term, priority should be given to foundational work on quality standardization: immediately launching a large-scale chemical composition survey of mainstream commercial ALD, integrating genomics for origin identification, establishing rapid and accurate identification methods based on multi-metabolite quantitative analysis and DNA barcoding technology, and formulating unified and feasible standards for raw medicinal materials. The most promising core active metabolites should be prioritized, with resources focused on completing systematic preclinical pharmacokinetic and pharmacodynamic studies, as well as preliminary acute toxicity and repeated-dose toxicity tests, to quickly obtain an initial assessment of their safety risks. Meanwhile, advanced technologies such as CRISPR screening, molecular docking, and metabolite probes should be employed to precisely identify their direct target sites.
Research on the mechanisms of compatibility in TCM formulations is also one of the priorities. Conducting studies on the synergistic principles and toxicity-reducing effects of pairing ALD with other botanical drugs is essential to provide a scientific basis for the modern application of TCM formulas. For compounds that have been identified as highly active but with low bioavailability, it is necessary to initiate the development of novel drug delivery systems, such as preparing their nanocrystals or phospholipid complexes, and to validate their efficacy enhancement and toxicity reduction in animal models. Additionally, launching small-scale exploratory clinical studies on TCM will help accumulate preliminary data and experience for larger trials.
The establishment of a complete industrial chain can maximize the internationalization of the ALD industry. Facilitating the formation of an integrated industrial chain, which is from large-scale cultivation of ALD bases to standardized extraction and production, and further to the development of final formulations, will help translate research achievements into real industrial applications and build a modern traditional Chinese medicine brand. Meanwhile, establishing an ALD research database to integrate chemical, pharmacological, toxicological, and clinical data will promote global collaboration and knowledge sharing among researchers.
Statements
Author contributions
JC: Conceptualization, Funding acquisition, Methodology, Writing – original draft. ZZ: Conceptualization, Writing – original draft, Writing – review and editing. LL: Conceptualization, Software, Writing – review and editing. GW: Supervision, Writing – review and editing. HY: Supervision, Writing – review and editing. XW: Conceptualization, Formal Analysis, Writing – review and editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This work was financially supported by the Intelligent Detection and Healthcare Research Team of Liuzhou Polytechnic University and the 2024 Major Scientific Research Project of Liuzhou Polytechnic University (2024AK06).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Abbreviations
ALD, Aucklandia lappa Decne.; AR, Aucklandiae Radix; ARR, Aristolochiae Radix; DSS, dextran sulfate sodium; E-nose, electronic nose; GC, gas chromatography; IBD, inflammatory bowel disease; ICPMS, inductively coupled plasma mass spectrometry; IR, Inulae Radix; LC, liquid chromatography; MBC, minimal bactericidal concentration; MIC, minimum inhibitory concentration; MS, mass spectrometry; NMR, nuclear magnetic resonance; TCM, traditional Chinese medicine; TLC, thin-layer chromatography; VR, Vladimiriae Radix.
References
1
Abdel-RahmanM.RezkM. M.Ahmed-FaridO. A.EssamS.Abdel MoneimA. E. (2020). Saussurea lappa root extract ameliorates the hazards effect of thorium induced oxidative stress and neuroendocrine alterations in adult Male rats. Environ. Sci. Pollut. Res.27 (12), 13237–13246. 10.1007/s11356-020-07917-y
2
AbouelwafaE.ZakiA.SabryO. M.El-ShiekhR. A.CaprioliG.Abdel-SattarE. (2024). Unveiling the chemical profiling and remarkable modulation of carbohydrate metabolism by costus root, Dolomiaea costus (Falc.) in streptozotocin (STZ)-induced diabetic rats. J. Ethnopharmacol.326, 117911. 10.1016/j.jep.2024.117911
3
AdelE. M.Al-TayawiT. S.OmerF. H.MohammedM. F. (2025). Phytochemical screening, antioxidant and antibacterial properties of alcoholic extract of Saussurea costus roots. Asian J. Dairy Food Res.44 (2), 209–215. 10.18805/ajdfr.DRF-448
4
AhmadA.WangC.-Y.TsaiA.-C.PengC.-Y.ChangY.-L.LeeK.-H.et al (2012). Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways. PLoS One7 (2), e31195. 10.1371/journal.pone.0031195
5
AhmedG. S.CoskunU. S. Ş. (2023). Investigation of antibacterial and antifungal activity of Saussurea costus root extracts. An. Acad. Bras. Ciênc.95 (Suppl. 1), e20230059–17. 10.1590/0001-3765202320230059
6
AhmedA.AhmadS.SoniK.LapaB.AfzalM.SharmaK.et al (2016). Suitable solvent and drying condition to enhance phenolics and extractive value of Saussurea costus. J. Ayurvedic Herb. Med.2 (5), 165–170. 10.31254/jahm.2016.2504
7
AhmedH. Y.KareemS. M.AtefA.SafwatN. A.ShehataR. M.YosriM.et al (2022). Optimization of supercritical carbon dioxide extraction of Saussurea costus oil and its antimicrobial, antioxidant, and anticancer activities. Antioxidants11 (10), 1960. 10.3390/antiox11101960
8
Al-ShaeriM. A. M.Al-brahimJ. S. (2023). Saussurea costus extract as bio mediator in synthesis iron oxide nanoparticles (IONPs) and their antimicrobial ability. PLoS One18 (3), e0282443. 10.1371/journal.pone.0282443
9
Al-ZayadiZ. A.ShananH. K.AkoolA. S. K. (2023). Evaluation of the anticancer effect of Saussurea costus root extract against induced hepatic and renal cancer in white mice: a histopathological Study. Adv. Animal Veterinary Sci.11 (7), 1065–1076. 10.17582/journal.aavs/2023/11.7.1065.1076
10
AlanaghE. N.GaroosiG.-a.HaddadR.MalekiS.LandínM.GallegoP. P. (2014). Design of tissue culture media for efficient Prunus rootstock micropropagation using artificial intelligence models. Plant Cell, Tissue Organ Cult.117 (3), 349–359. 10.1007/s11240-014-0444-1
11
AlghabbanA. J. M.BakrL.ElbatawyA. A.El AtrashA.ToussonE. (2024). Impact of Saussurea lappa against foodborne parasite Trichinella spiralis experimental infections induced variation in DNA damage, oxidative stress and PCNA expression in rat skeletal muscles. Toxicol. Res.13 (2), tfae047–6. 10.1093/toxres/tfae047
12
AlshubailyF. A. (2019). Enhanced antimycotic activity of nanoconjugates from fungal chitosan and Saussurea costus extract against resistant pathogenic Candida strains. Int. J. Biol. Macromol.141, 499–503. 10.1016/j.ijbiomac.2019.09.022
13
AmenY.AbdelwahabG.HeraizA. A.SallamM.OthmanA. (2025). Exploring sesquiterpene lactones: structural diversity and antiviral therapeutic insights. RSC Adv.15 (3), 1970–1988. 10.1039/d4ra08125k
14
AttallahN. G. M.KabbashA.NegmW. A.ElekhnawyE.BinsuwaidanR.Al-FakhranyO. M.et al (2023). Protective potential of Saussurea costus (Falc.) Lipsch. Roots against cyclophosphamide-induced pulmonary injury in rats and its in vitro antiviral effect. Pharmaceuticals16 (2), 318. 10.3390/ph16020318
15
BaiL. (2023). Effect of muxiang shunqi pills combined with external application of nuangong paste on gastrointestinal adverse reactions and recovery of gastrointestinal function after cesarean section. Chin. Med. Mod. Distance Educ. China21 (20), 102–105. 10.3969/j.issn.1672⁃2779.2023.20.034
16
BaiL.WuC.LeiS.ZouM.WangS.ZhangZ.et al (2023). Potential anti-gout properties of wuwei shexiang pills based on network pharmacology and pharmacological verification. J. Ethnopharmacol.305, 116147. 10.1016/j.jep.2023.116147
17
Ben AbdelmalekI.AlhmdiT. A. A.Ben BachaA.KrayemN. (2025). Unlocking the therapeutic potential of saussurea costus: purification and functional characterization of α-amylase inhibitors. Front. Bioeng. Biotechnol.13, 1535751. 10.3389/fbioe.2025.1535751
18
BezerraJ. J. L.PinheiroA. A. V.de OliveiraA. F. M. (2025). Chemical composition and anticancer activity of essential oils from cyperaceae species: a comprehensive review. Sci. Pharm.93, 9. 10.3390/scipharm93010009
19
BhattiH. N.KhanS. S.KhanA.RaniM.AhmadV. U.ChoudharyM. I. (2014). Biotransformation of monoterpenoids and their antimicrobial activities. Phytomedicine21 (12), 1597–1626. 10.1016/j.phymed.2014.05.011
20
BhushanA.RaniD.LoneB. A.TabassumM.GuptaA. P.MondheD. M.et al (2023a). Costunosides A-C: cytotoxic sesquiterpene lactones from the rhizomes of Aucklandia costus Falc. Auckl. costus Falc. Nat. Prod. Res.38 (23), 4113–4124. 10.1080/14786419.2023.2275743
21
BhushanA.RaniD.TabassumM.KumarS.GuptaP. N.GairolaS.et al (2023b). HPLC-PDA method for quantification of bioactive compounds in crude extract and fractions of Aucklandia costus falc. and cytotoxicity studies against cancer cells. Molecules28 (12), 4815. 10.3390/molecules28124815
22
BinobeadM. A.AzizI. M.IbrahimS. M.AljowaieR. M. (2024). Chemical composition and bioactivities of the methanol root extracts of Saussurea costus. Open Chem.22, 20240002. 10.1515/chem-2024-0002
23
BlazquezM. A.LiuQ.MajdiM.CankarK.GoedbloedM.CharnikhovaT.et al (2011). Reconstitution of the costunolide biosynthetic pathway in yeast and Nicotiana benthamiana. PLoS One6 (8), e23255. 10.1371/journal.pone.0023255
24
CaiY.GaoK.PengB.XuZ.PengJ.LiJ.et al (2021). Alantolactone: a natural plant extract as a potential therapeutic agent for cancer. Front. Pharmacol.12, 781033. 10.3389/fphar.2021.781033
25
CaiX.YangC.QinG.ZhangM.BiY.QiuX.et al (2022). Antimicrobial effects and active compounds of the root of Aucklandia Lappa Decne (Radix Aucklandiae). Front. Chem.10, 872480. 10.3389/fchem.2022.872480
26
CaoS.ZhangY.WangX.BaL.ZhaoZ.DongG.et al (2025). Carvacrol treatment enhances the quality of peach fruit by regulating the metabolism of reactive oxygen species and the phenylpropanoid pathway. LWT231, 118329. 10.1016/j.lwt.2025.118329
27
ChandrasenaD.DiFonzoC.ByrneA. (2011). An aphid-dip bioassay to evaluate susceptibility of soybean aphid (Hemiptera: aphididae) to pyrethroid, organophosphate, and neonicotinoid insecticides. J. Econ. Entomol.104 (4), 1357–1363. 10.1603/ec10414
28
ChenZ. (2025). Research on the cultivation and management technology of Chinese herbal medicine Aucklandia lappa Decne. Seed Sci. & Technol.43 (1), 77–79. 10.19904/j.cnki.cn14-1160/s.2025.01.025
29
ChenY.FangJ.-Y. (2025). The role of colonic microbiota amino acid metabolism in gut health regulation. Cell Insight4 (2), 100227. 10.1016/j.cellin.2025.100227
30
ChenZ.LiQ.YuZ.YanX.WangW.XieY.et al (2020). Analysis of the similarities and differences between Auclandia and Vladimirae rhizomes by chemical profiling and chemometric analysis. J. Ethnopharmacol.255, 112719. 10.1016/j.jep.2020.112719
31
ChenY.MiaoZ.ShengX.LiX.MaJ.XuX.et al (2022a). Sesquiterpene lactones-rich fraction from Aucklandia lappa Decne. alleviates dextran sulfate sodium induced ulcerative colitis through co-regulating MAPK and Nrf2/Hmox-1 signaling pathway. J. Ethnopharmacol.295, 115401. 10.1016/j.jep.2022.115401
32
ChenZ.WeiC.YuZ.YangK.HuangZ.HuH.et al (2022b). An effective method for preventing cholestatic liver injury of Aucklandiae Radix and Vladimiriae Radix: inflammation suppression and regulate the expression of bile acid receptors. J. Ethnopharmacol.294, 115330. 10.1016/j.jep.2022.115330
33
ChenX.LiF.XieX.ZhaoL.ZanK. (2023). Comparison the content changes of heavy metals and harmful elements in Aucklandiae Radix before and after processing by ICP-MS. Special Wild Econ. Animal Plant Res.45 (4), 135–138. 10.16720/j.cnki.tcyj.2023.127
34
ChengC.-L.ChenK.-J.ShihP.-H.LuL.-Y.HungC.-F.LinW.-C.et al (2006). Chronic renal failure rats are highly sensitive to aristolochic acids, which are nephrotoxic and carcinogenic agents. Cancer Lett.232 (2), 236–242. 10.1016/j.canlet.2005.02.021
35
China Pharmacopoeia Committee (2020a). Pharmacopoeia of the People'S Republic of China - muxiang. Beijing: China Medical Science and Technology Press.
36
China Pharmacopoeia Committee (2020b). Pharmacopoeia of the People'S Republic of China - chuanmuxiang. Beijing: China Medical Science and Technology Press.
37
China Pharmacopoeia Committee (2020c). Pharmacopoeia of the People'S Republic of China - liuwei Muxiang San. Beijing: China Medical Science and Technology Press.
38
China Pharmacopoeia Committee (2020d). Pharmacopoeia of the People'S Republic of China - muxiang binglang wan. Beijing: China Medical Science and Technology Press.
39
China Pharmacopoeia Committee (2020e). Pharmacopoeia of the People'S Republic of China - muxiang fenqi wan. Beijing: China Medical Science and Technology Press.
40
China Pharmacopoeia Committee (2020f). Pharmacopoeia of the People'S Republic of China - muxiang shunqi wan. Beijing: China Medical Science and Technology Press.
41
China Pharmacopoeia Committee (2020g). Pharmacopoeia of the People'S Republic of China - tumuxiang. Beijing: China Medical Science and Technology Press.
42
ChoiD. H.KimJ. Y.AnJ. H.SungS. H.KongH. S. (2021). Effects of saussurea costus on apoptosis imbalance and inflammation in benign prostatic hyperplasia. J. Ethnopharmacol.279, 114349. 10.1016/j.jep.2021.114349
43
ChuC.-Y.HoP.-H.ChoY.-T. (2019). Radix Aucklandiae (dried root of Saussurea costus)-induced acute generalized exanthematous pustulosis confirmed by patch testing. Dermatol. Sin.37 (2), 98–102. 10.4103/ds.ds_16_18
44
ChunJ.ChoiR. J.KhanS.LeeD.-S.KimY.-C.NamY.-J.et al (2012). Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells. Int. Immunopharmacol.14 (4), 375–383. 10.1016/j.intimp.2012.08.011
45
da SilvaL. P.BorgesB. A.VelosoM. P.Chagas-PaulaD. A.GonçalvesR. V.NovaesR. D. (2021). Impact of sesquiterpene lactones on the skin and skin-related cells? A systematic review of in vitro and in vivo evidence. Life Sci.265, 118815. 10.1016/j.lfs.2020.118815
46
DaiC.LiuN.ChenW.QianW.HouX. (2012). Simo decoction promotes contraction of antral circular smooth muscle mainly via muscarinic M3 receptor. J. Ethnopharmacol.144 (2), 270–276. 10.1016/j.jep.2012.09.008
47
DongS.MaL.-Y.LiuY.-T.YuM.JiaH.-M.ZhangH.-W.et al (2018). Pharmacokinetics of costunolide and dehydrocostuslactone after oral administration of Radix aucklandiae extract in normal and gastric ulcer rats. J. Asian Nat. Prod. Res.20 (11), 1055–1063. 10.1080/10286020.2018.1489379
48
ElshaerS. E.HamadG. M.HafezE. E.BaghdadiH. H.El-DemerdashF. M.Simal-GandaraJ. (2022). Root extracts of Saussurea costus as prospective detoxifying food additive against sodium nitrite toxicity in male rats. Food Chem. Toxicol.166, 113225. 10.1016/j.fct.2022.113225
49
FengZ.-G.Cai-RangX.-D.TanX.-Y.LiC.-Y.ZengS.-Y.LiuY.et al (2023). Processing methods and the underlying detoxification mechanisms for toxic medicinal materials used by ethnic minorities in China: a review. J. Ethnopharmacol.305, 116126. 10.1016/j.jep.2022.116126
50
FengY.-L.XuX.-R.ZhuQ.-M.ChangJ.ZhangH.-L.WangN.et al (2024). Aucklandiae radix targeted PKM2 to alleviate ulcerative colitis: insights from the photocrosslinking target fishing technique. Phytomedicine134, 155973. 10.1016/j.phymed.2024.155973
51
Ferreira-GuerraM.Marquès-BuenoM.Mora-GarcíaS.Caño-DelgadoA. I. (2020). Delving into the evolutionary origin of steroid sensing in plants. Curr. Opin. Plant Biol.57, 87–95. 10.1016/j.pbi.2020.06.005
52
GaitnieksT.KlavinaD.MuiznieksI.PennanenT.VelmalaS.VasaitisR.et al (2016). Impact of Heterobasidion root-rot on fine root morphology and associated fungi in picea abies stands on peat soils. Mycorrhiza26 (5), 465–473. 10.1007/s00572-016-0685-4
53
GaoT.JiangM.DengB.ZhangZ.FuQ.FuC. (2020). Aurantii fructus: a systematic review of ethnopharmacology, phytochemistry and pharmacology. Phytochem. Rev.20 (5), 909–944. 10.1007/s11101-020-09725-1
54
GaoY.ZhuangT.GaoL.GuoZ.YuJ.TangY. (2024). Effects of muxiang binglang Wan on tumor necrosis factor a content and pepsinogen in mice. J. Baotou Med. Coll.40 (4), 15–20. 10.16833/j.cnki.jbmc.2024.04.003
55
GomaaH. F.AbdelmalekI. B.Abdel-WahhabK. G. (2021). The anti-diabetic effect of some plant extracts against Streptozotocin - induced diabetes type 2 in Male albino rats. Endocr. Metab. Immune21 (8), 1431–1440. 10.2174/1871530320666201016145502
56
GuccioneC.RosG.GalloriS.BergonziM. C.BiliaA. R. (2017). Rapid and efficient extraction and HPLC analysis of sesquiterpene lactones from Aucklandia lappa root. Nat. Prod. Commun.12 (2), 1934578X1701200218–216. 10.1177/1934578x1701200218
57
HajjiH.AlaqarbehM.LakhlifiT.AjanaM. A.AlsakhenN.BouachrineM. (2022). Computational approach investigation bioactive molecules from saussurea costus plant as SARS-CoV-2 main protease inhibitors using reverse docking, molecular dynamics simulation, and pharmacokinetic ADMET parameters. Comput. Biol. Med.150, 106209. 10.1016/j.compbiomed.2022.106209
58
HassonS. S.H Al-ShubiA. S.Al-BusaidiJ. Z.Al-BalushiM. S.HakkimF. L.RashanL.et al (2018). Potential of Aucklandia lappa Decne Ethanolic extract to trigger apoptosis of human T47D and Hela cells. Asian pac. J. Cancer19 (7), 1917–1925. 10.22034/APJCP.2018.19.7.1917
59
HeJ.LiuL.LiuX.ChenH.LiuK.HuangN.et al (2022). Epoxymicheliolide prevents dextran sulfate sodium-induced colitis in mice by inhibiting TAK1-NF-κB pathway and activating Keap1-NRF2 signaling in macrophages. Int. Immunopharmacol.113, 109404. 10.1016/j.intimp.2022.109404
60
HoS.-C.KuoC.-T. (2014). Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel (Citri reticulatae pericarpium). Food Chem. Toxicol.71, 176–182. 10.1016/j.fct.2014.06.014
61
HongW.ChenX.XiaoJ.ChenG.YangJ.ZhangP.et al (2025). Dehydrocostus lactone attenuates atherogenesis by promoting cholesterol efflux and inhibiting inflammation via TLR2/PPAR-γ/NF-κB signaling pathway. Mol. Med.31 (1), 243. 10.1186/s10020-025-01265-8
62
HouchiS.MessasmaZ. (2022). Exploring the inhibitory potential of Saussurea costus and Saussurea involucrata phytoconstituents against the Spike glycoprotein receptor binding domain of SARS-CoV-2 Delta (B.1.617.2) variant and the main protease (Mpro) as therapeutic candidates, using molecular docking, DFT, and ADME/Tox studies. J. Mol. Struct.1263, 133032. 10.1016/j.molstruc.2022.133032
63
HsuY.-L.WuL.-Y.KuoP.-L. (2009). Dehydrocostuslactone, a medicinal plant-derived sesquiterpene lactone, induces apoptosis coupled to endoplasmic reticulum stress in liver cancer cells. J. Pharmacol. Exp. Ther.329 (2), 808–819. 10.1124/jpet.108.148395
64
HuangZ.WeiC.YangK.YuZ.WangZ.HuH. (2021). Aucklandiae radix and vladimiriae radix: a systematic review in ethnopharmacology, phytochemistry and pharmacology. J. Ethnopharmacol.280, 114372. 10.1016/j.jep.2021.114372
65
HuangY. J.TongH. Y.HuangX. J.XiaoX. C.DongY.IqbalM. S. (2022a). Anshen-buxin-liuwei pill, a Mongolian medicinal formula could alleviate cardiomyocyte hypoxia/reoxygenation injury via mitochondrion pathway. Mol. Biol. Rep.49 (2), 885–894. 10.1007/s11033-021-06867-z
66
HuangZ.XuC.ZhaoL.WeiC.WuY.QiuJ.et al (2022b). Preparation, optimization and in vivo study of gastric floating tablets of constunolide and dehydrocostus lactone with ideal therapeutic effect on gastric diseases. J. Drug Deliv. Sci. Technol.78, 103942. 10.1016/j.jddst.2022.103942
67
HuangX.-F.XueY.YongL.WangT.-T.LuoP.QingL.-S. (2024). Chemical derivatization strategies for enhancing the HPLC analytical performance of natural active triterpenoids. J. Pharm. Anal.14 (3), 295–307. 10.1016/j.jpha.2023.07.004
68
IdrissH.SiddigB.González-MaldonadoP.ElkhairH. M.AlakhrasA. I.AbdallahE. M.et al (2023). Inhibitory activity of saussurea Costus extract against bacteria, Candida, herpes, and SARS-CoV-2. Plants12 (3), 460. 10.3390/plants12030460
69
JiangH.WangX. (2023). Biosynthesis of monoterpenoid and sesquiterpenoid as natural flavors and fragrances. Biotechnol. Adv.65, 108151. 10.1016/j.biotechadv.2023.108151
70
JoH.-G.LeeG.-Y.BaekC. Y.SongH. S.LeeD. (2021). Analgesic and anti-inflammatory effects of Aucklandia lappa root extracts on acetic acid-induced writhing in mice and monosodium iodoacetate-induced osteoarthritis in rats. Plants10, 42. 10.3390/plants10010042
71
JomovaK.AlomarS. Y.ValkoR.LiskaJ.NepovimovaE.KucaK.et al (2025). Flavonoids and their role in oxidative stress, inflammation, and human diseases. Chem. Biol. Interact.413, 111489. 10.1016/j.cbi.2025.111489
72
JuliantiT.HataY.ZimmermannS.KaiserM.HamburgerM.AdamsM. (2011). Antitrypanosomal sesquiterpene lactones from Saussurea costus. Fitoterapia82 (7), 955–959. 10.1016/j.fitote.2011.05.010
73
KellingM.DimzaM.BartlettA.TraktuevD. O.DuarteJ. D.KeeleyE. C. (2024). Omega-3 fatty acids in the treatment of heart failure. Curr. Prob. Cardiol.49 (9), 102730. 10.1016/j.cpcardiol.2024.102730
74
KosanamS.PasupulaR.JamesD. (2024). Exploring the anticancer potential of Saussurea costus phytoconstituents against prostate cancer using virtual screening and molecular docking. J. Nat. Remedies24 (11), 2459–2467. 10.18311/jnr/2024/41950
75
KumarS.PandeyA. K. (2022). Bio-efficacy of various insecticides against white grubs (Coleoptera: scarabaeidae) infesting sugarcane. Int. J. Trop. Insect Sci.42 (5), 3319–3325. 10.1007/s42690-022-00820-8
76
KumarA.KumarS.KumarD.AgnihotriV. K. (2014). UPLC/MS/MS method for quantification and cytotoxic activity of sesquiterpene lactones isolated from Saussurea lappa. J. Ethnopharmacol.155 (2), 1393–1397. 10.1016/j.jep.2014.07.037
77
KumarR.BhardwajP.SoniM.SinghR.ChoudharyS.VirmaniN.et al (2024a). Modulation of mammary tumour progression using murine model by ethanol root extract of Saussurea costus (falc.) lipsch. J. Ethnopharmacol.319, 117302. 10.1016/j.jep.2023.117302
78
KumarR.ChoudharyS.SoniM.SinghR.KumarS.AsraniR. K. (2024b). Augmentation of cytotoxicity and apoptotic activity in human breast cancer MCF-7 cells by Saussurea costus (Falc.) Lipsch roots. Ann. Phytomedicine13 (2), 433–438. 10.54085/ap.2024.13.2.42
79
LeeS.KimS.-B.LeeJ.ParkJ.ChoiS.HwangG. S.et al (2020). Evaluation of anti-colitis effect of KM1608 and biodistribution of dehydrocostus lactone in mice using bioimaging analysis. Plants9 (9), 1175. 10.3390/plants9091175
80
LiJ.LiM.YeK.JiangQ.WangM.WenX.et al (2021a). Chemical profile of xian-he-cao-chang-yan formula and its effects on ulcerative colitis. J. Ethnopharmacol.267, 113517. 10.1016/j.jep.2020.113517
81
LiR.-l.ZhangQ.LiuJ.HeL.-y.HuangQ.-w.PengW.et al (2021b). Processing methods and mechanisms for alkaloid-rich Chinese herbal medicines: a review. J. Integr. Med.19 (2), 89–103. 10.1016/j.joim.2020.12.003
82
LiX.WangL.MaY.HuangP. (2021c). Study on the processing technology of Aucklandia lappa Decne. Strait Pharm. J.33 (10), 26–28.
83
LiH.-B.BaiS.-Q.ShuT.-Y.WangQ.ChenH.SuL.-H.et al (2024a). Lappanolides A−N, fourteen undescribed sesquiterpenoids from Saussurea costus (Syn. Saussurea lappa) and their anti HBV activity. Phytochemistry226, 114207. 10.1016/j.phytochem.2024.114207
84
LiS.-Y.XuD.-Q.ChenY.-Y.FuR.-J.TangY.-P. (2024b). Several major herb pairs containing Coptidis rhizoma: a review of key traditional uses, constituents and compatibility effects. Front. Pharmacol.15, 1399460. 10.3389/fphar.2024.1399460
85
LiY.ChenY.ZhouY.HeJ.ZhouQ.WangM. (2024c). Unveiling the potentials and action mechanisms of Citri reticulatae Pericarpium as an anti‐inflammatory food. Food Front.6, 163–184. 10.1002/fft2.506
86
LiangS.ChenR.CirenZ.JiangG.DuL. (2024). Chemical composition of volatile oils from different processed products of Aucklandia Lappa decne. and Vladimiria Souliei (Franch.) ling based on Gaschromatography-Mass spectrometry. J. Chengdu Univ. TCM47 (2), 1–10. 10.13593/j.cnki.51-1501/r.2024.0.001
87
LimJ. S.LeeS. H.LeeS. R.LimH. J.RohY. S.WonE. J.et al (2020). Inhibitory effects of Aucklandia lappa decne. Extract on inflammatory and oxidative responses in LPS-Treated macrophages. Molecules25 (6), 1336. 10.3390/molecules25061336
88
LiuX.-n.LiH.-m.WangS.-p.ZhangJ.-z.LiuD.-l. (2021). Sesquiterpene lactones of Aucklandia lappa: pharmacology, pharmacokinetics, toxicity, and structure–activity relationship. Chin. Herb. Med.13 (2), 167–176. 10.1016/j.chmed.2020.11.005
89
LuJ.-j.AliA.HeE.-q.YanG.-q.ArakT.-u.GaoS.-J. (2019). Establishment of an open, sugar-free tissue culture system for sugarcane micropropagation. Sugar Tech.22 (1), 8–14. 10.1007/s12355-019-00758-1
90
LuM.ChuZ.WangL.LiangC.SunP.XiongS.et al (2020). Pharmacokinetics and tissue distribution of four major bioactive components in rats after oral administration of Xianglian pill. Biomed. Chromatogr.34 (3), e4770. 10.1002/bmc.4770
91
LuT.YuH. J.WangT. Y.ZhangT. Y.ShiC. H.JiangW. J. (2022). Influence of the electrical conductivity of the nutrient solution in different phenological stages on the growth and yield of cherry tomato. Horticulturae8 (5), 378. 10.3390/horticulturae8050378
92
LuoJ.-n.LiJ.-y.WangH.WangZ.-x.DingY.SunH.et al (2024). Content determination of aristolochic acid Ⅰ and AristolochicaAcid Ⅱ in Arastolochia moupinensis Franch. UPLC-MS/MS. Mod. Chin. Med.26 (8), 1326–1331. 10.13313/j.issn.1673-4890.20230615001
93
LyuH.-Y.BaoM.-Y.IoC.-C.XiongH.-M.ChenF.-L.BaiL.-P.et al (2023). Sesquiterpenoids from the roots of Aucklandia costus and their anti-inflammatory activities. Fitoterapia169, 105604. 10.1016/j.fitote.2023.105604
94
MammateN.El oumariF. E.ImtaraH.BelchkarS.Benjelloun TouimiG.Al-ZharaniM.et al (2023). Anti-struvite, antimicrobial, and anti-inflammatory activities of aqueous and ethanolic extracts of Saussurea costus (Falc) lipsch asteraceae. Molecules28 (2), 667. 10.3390/molecules28020667
95
MengC.WangP.HaoZ.GaoZ.LiQ.GaoH.et al (2021). Ecological and health risk assessment of heavy metals in soil and Chinese herbal medicines. Environ. Geochem. Health44 (3), 817–828. 10.1007/s10653-021-00978-z
96
MirF. H.TanveerS.BhartiP.ParaB. A. (2024). Anthelmintic activity of Saussurea costus (Falc.) Lipsch. Against Ascaridia galli, a pathogenic nematode in poultry: in vitro and in vivo studies. Acta Parasitol.69 (2), 1192–1200. 10.1007/s11686-024-00837-8
97
MishraY. K.AminaM.Al MusayeibN. M.AlarfajN. A.El-TohamyM. F.OrabyH. F.et al (2020). Biogenic green synthesis of MgO nanoparticles using Saussurea costus biomasses for a comprehensive detection of their antimicrobial, cytotoxicity against MCF-7 breast cancer cells and photocatalysis potentials. PLoS One15 (8), e0237567. 10.1371/journal.pone.0237567
98
MushtaqM.AminQ. A.WaniT. A.BhatT. A.ParveenS.BeighM. A. (2025). Supercritical fluid extraction and micro-encapsulation of Saussurea costus roots for next gen functional foods: antioxidant potential, surface morphology and anti-diabetic potential. Food Chem.495, 146290. 10.1016/j.foodchem.2025.146290
99
PaudelP.ParkC. H.JungH. A.YokozawaT.ChoiJ. S. (2020). A systematic review on anti-alzheimer's disease activity of prescription Kangen-karyu. Drug Discov. & Ther.14 (2), 61–66. 10.5582/ddt.2020.03013
100
PengM.ZhaoH.FuJ.ZhangZ.YuanZ.ZhangB. (2025). Structural characterization of two low‐molecular‐weight polysaccharides from the roots of Aucklandia lappa Decne. and their bioactivity on the gut microbiota of immunocompromised mice. J. Food Sci.90 (6), e70013–e70016. 10.1111/1750-3841.70013
101
PupilliF.BarcacciaG. (2012). Cloning plants by seeds: inheritance models and candidate genes to increase fundamental knowledge for engineering apomixis in sexual crops. J. Biotechnol.159 (4), 291–311. 10.1016/j.jbiotec.2011.08.028
102
QiaoL.JiaoY.LiX.ZhangY.LuL.ZhangX.et al (2023). Herbal smoke fumigation for controlling Penicillium crustosum in fresh walnuts. Food Res. Int.167, 112709. 10.1016/j.foodres.2023.112709
103
RasulA.KhanM.AliM.LiJ.LiX.JannM. W.et al (2013). Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone. Sci. World J.2013 (1), 248532. 10.1155/2013/248532
104
RenqingD.FengX.LuosangD.HuaQ.SanZ. (2023). Molecular mechanism of Tibetan medicine Liuwei Muxiang pills for treating chronic Non atrophic Gastritis based on serum active chemical components. Plateau Sci. Res.7 (3), 58–71. 10.16249/j.cnki.2096-4617.2023.03.007
105
SeoC. S.ShinH. K. (2015). Simultaneous determination of three sesquiterpene lactones in Aucklandia lappa decne by high-performance liquid chromatography. Pharmacogn. Mag.11 (43), 562–566. 10.4103/0973-1296.160471
106
SeoC. S.LimH. S.JeongS. J.ShinH. K. (2015). Anti-allergic effects of sesquiterpene lactones from the root of Aucklandia lappa decne. Mol. Med. Rep.12 (5), 7789–7795. 10.3892/mmr.2015.4342
107
ShatiA. A.AlkahtaniM. A.AlfaifiM. Y.ElbehairiS. E. I.ElsaidF. G.PrasannaR.et al (2020). Secondary metabolites of saussurea costus leaf extract induce apoptosis in breast, liver, and Colon cancer cells by Caspase‐3‐Dependent intrinsic pathway. Biomed. Res. Int.2020 (1), 1608942. 10.1155/2020/1608942
108
ShumK. C.ChenF.LiS. L.WangJ.ButP. P. H.ShawP. C. (2007). Authentication of Radix aucklandiae and its substitutes by GC‐MS and hierarchical clustering analysis. J. Sep. Sci.30 (18), 3233–3239. 10.1002/jssc.200700232
109
SmirleM. J.ZurowskiC. L.LoweryD. T.MostafaA. M. (2013). Insecticide susceptibility of three species of cutworm (lepidoptera: noctuidae) pests of grapes. J. Econ. Entomol.106 (5), 2135–2140. 10.1603/ec13110
110
SongY. Y.ZhangT. T.TangH.XuL.XingY. P.ZhaoR.et al (2021). The complete mitochondrial genome of Aucklandia lappa decne. (asteraceae, aucklandia falc.). Mitochondrial DNA B6 (6), 1691–1693. 10.1080/23802359.2021.1914524
111
SongS.QiuR.JinX.ZhouZ.YanJ.OuQ.et al (2022a). Mechanism exploration of ancient pharmaceutic processing (Paozhi) improving the gastroprotective efficacy of Aucklandiae Radix. J. Ethnopharmacol.287, 114911. 10.1016/j.jep.2021.114911
112
SongS.ZhouJ.LiY.LiuJ.LiJ.ShuP. (2022b). Network pharmacology and experimental verification based research into the effect and mechanism of Aucklandiae Radix–Amomi fructus against gastric cancer. Sci. Rep.12 (1), 9401. 10.1038/s41598-022-13223-z
113
SongS.WeiD.QiuR.HuangY.HeJ.DuX.et al (2023). Study on the protective effect of ethanol extract from Aucklandiae Radix on lipopolysaccharide-induced liver injury. China J. Traditional Chin. Med. Pharm.38 (12), 6020–6023.
114
SongS.QiuR.HuangY.ZhouZ.YanJ.OuQ.et al (2024). Study on the mechanism of hepatotoxicity of Aucklandiae radix through liver metabolomics and network pharmacology. Toxicol. Res.13 (4), tfae123–13. 10.1093/toxres/tfae123
115
SunM.ZhanH.LongX.AlsayedA. M.WangZ.MengF.et al (2024). Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation. Phytomedicine128, 155371. 10.1016/j.phymed.2024.155371
116
SuoS.LaiY.LiM.SongQ.CaiJ.ZhaoJ.et al (2018). Phytochemicals, pharmacology, clinical application, patents, and products of Amomi fructus. Food Chem. Toxicol.119, 31–36. 10.1016/j.fct.2018.05.051
117
TanW.LiK.LiuD.XingW. (2023). Cercospora leaf spot disease of sugar beet. Plant Signal. & Behav.18 (1), 2214765. 10.1080/15592324.2023.2214765
118
VogtT. (2010). Phenylpropanoid biosynthesis. Mol. Plant3 (1), 2–20. 10.1093/mp/ssp106
119
WangF.-Y.ZhongL. L. D.KangN.DaiL.LvL.BianL.-Q.et al (2016). Chinese herbal formula for postprandial distress syndrome: study protocol of a double-blinded, randomized, placebo-controlled trial. Eur. J. Integr. Med.8 (5), 688–694. 10.1016/j.eujim.2016.03.010
120
WangX.GiustiA.NyA.de WitteP. A. (2020a). Nephrotoxic effects in zebrafish after prolonged exposure to aristolochic acid. Toxins12 (4), 217. 10.3390/toxins12040217
121
WangY.FanX.-x.YangJ.WangZ.-q.WangN.ChenJ.-q.et al (2020b). Research progress on terpenes and pharmacological effects of Saussurea lappa. China J. Chin. Materia Medica45 (24), 5917–5928. 10.19540/j.cnki.cjcmm.20200903.601
122
WangY. G.ZhangN.ChenC. L.JiangY. C.LiuT. (2023). Nonlinear adaptive generalized predictive control for PH model of nutrient solution in plant factory based on ANFIS. Processes11 (8), 2317. 10.3390/pr11082317
123
WangX. r.ZhangJ. t.GuoX. h.LiM. h.JingW. g.ChengX. l.et al (2024). Digital identification of Aucklandiae radix, Vladimiriae radix, and Inulae radix based on multivariate algorithms and UHPLC‐QTOF‐MS analysis. Phytochem. Anal.36, 92–100. 10.1002/pca.3421
124
WuG.LiZ.ZhengY.ZhangY.LiuL.GongD.et al (2022). Supplementing cholamine to diet lowers laying rate by promoting liver fat deposition and altering intestinal microflora in laying hens. Poult. Sci.101 (10), 102084. 10.1016/j.psj.2022.102084
125
WuM.-l.BaoS.-y.HuangH.-x.SunL.-e. (2024a). Quality standard of bran Radix Aucklandiae formula granules based on standard decoction. Cent. South Pharm.22 (11), 3014–3020. 10.7539/j.issn.1672-2981.2024.11.029
126
WuY.WuJ.LiL.OuYangH.WuL.YangC.et al (2024b). A gel plaster in the form of nipple cover: a comfortable and safe transdermal delivery method for mammary hyperplasia. Int. J. Pharm.662, 124500. 10.1016/j.ijpharm.2024.124500
127
WuH.LuoJ.ChenY.ZhangJ.HanT.TanB.et al (2025). Integrated chemometrics and biological validation assay to identify α,β-unsaturated carbonyl compounds as key anti-inflammatory and antioxidant agents in Aucklandiae Radix. Fitoterapia186, 106797. 10.1016/j.fitote.2025.106797
128
XuR.ZhouG.PengY.WangM.LiX. (2015). Pharmacokinetics, tissue distribution and excretion of Isoalantolactone and alantolactone in rats after oral administration of Radix inulae extract. Molecules20 (5), 7719–7736. 10.3390/molecules20057719
129
XuY.GeX.LvY.YangZ.LiF.YangZ. (2025). Engineering plant hosts for high-efficiency accumulation of flavonoids: advances, challenges and perspectives. Biotechnol. Adv.84, 108692. 10.1016/j.biotechadv.2025.108692
130
XueR.DengC.CaoH.ZhangK.LuT.MaoC. (2020). Quality assessment of raw and baked Aucklandia lappa Decne. by color measurement and fingerprint analysis. J. Sep. Sci.43 (15), 3017–3026. 10.1002/jssc.202000308
131
YanX.WangW.ChenZ.XieY.LiQ.YuZ.et al (2020). Quality assessment and differentiation of Aucklandiae radix and Vladimiriae Radix based on GC-MS fingerprint and chemometrics analysis: basis for clinical application. Anal. Bioanal. Chem.412 (7), 1535–1549. 10.1007/s00216-019-02380-2
132
YangH. J.KimM. J.KangS.MoonN. R.KimD. S.LeeN. R.et al (2017). Topical treatments of Saussurea costus root and Thuja orientalis L. synergistically alleviate atopic dermatitis-like skin lesions by inhibiting protease-activated receptor-2 and NF-κB signaling in HaCaT cells and Nc/Nga mice. J. Ethnopharmacol.199, 97–105. 10.1016/j.jep.2017.01.055
133
YangH.-S.MaukiD. H.ZhengY.-X.WangT.-H.HeX.-Y. (2025). Terpenoids: a promising traditional chinese medicine for neuropathic pain relief. Pharmacol. Res.216, 107789. 10.1016/j.phrs.2025.107789
134
YangW.GuoD.CaoW.PanX.XueY.ZhangJ.et al (2020). Effects of 27 strains of Arbuscular Mycorrhizal Fungi inoculation on physiology and biochemistry and major components of terpenoids in potted saussurea costus. Chin J. Trop. Crop.41, 1822–1830. 10.3969/j.issn.1000-2561.2020.09.015
135
YiY.-n.ChengX.-m.LiuL.-a.HuG.-y.CaiG.-x.DengY.-d.et al (2011). HPLC fingerprint with multi-components analysis for quality consistency evaluation of traditional Chinese medicine si-mo-tang oral liquid preparation. Chem. Res. Chin. Univ.27 (5), 756–763.
136
YinH.ZhuangY.-b.LiE. e.BiH.-p.ZhouW.LiuT. (2015). Heterologous biosynthesis of costunolide in Escherichia coli and yield improvement. Biotechnol. Lett.37 (6), 1249–1255. 10.1007/s10529-015-1784-6
137
YuanY.HuQ.LiuL.XieF.YangL.LiY.et al (2022). Dehydrocostus lactone suppresses Dextran Sulfate sodium-induced colitis by targeting the IKKα/β-NF-κB and Keap1-Nrf2 signalling pathways. Front. Pharmacol.13, 817596. 10.3389/fphar.2022.817596
138
YuanW.YuX.WuH.XuM.DaiY.XinruL.et al (2024). Research progress on sesquiterpenoid components and pharmacological effects of Aucklandiae Radix. Yunnan Chem. Technol.51 (8), 1–5. 10.3969/j.issn.1004-275X.2024.08.01
139
ZengL. R.PanB. W.CaiJ.LiuL. J.DongZ. C.ZhouY.et al (2024). Construction, structural modification, and bioactivity evaluation of pentacyclic triterpenoid privileged scaffolds in active natural products. RSC Adv.14 (53), 39436–39461. 10.1039/d4ra07602h
140
ZhangJ.GaoW.LiuZ.ZhangZ. (2013). Identification and simultaneous determination of twelve active components in the methanol extract of traditional medicine weichang’an pill by HPLC-DAD-ESI-MS/MS. Iran. J. Pharm. Res.12 (1), 15–24.
141
ZhangJ.HuX.GaoW.QuZ.GuoH.LiuZ.et al (2014). Pharmacokinetic study on costunolide and dehydrocostuslactone after oral administration of traditional medicine Aucklandia lappa Decne. by LC/MS/MS. J. Ethnopharmacol.151 (1), 191–197. 10.1016/j.jep.2013.10.024
142
ZhangM.ZhangC.ChenY.FuX. (2015). Three statistical experimental designs for enhancing yield of active compounds from herbal medicines and anti motion sickness bioactivity. Pharmacogn. Mag.11 (43), 435–443. 10.4103/0973-1296.160444
143
ZhangJ.WeiZ.ZhangA.ZhaoY.ZhaoG.CaiX.et al (2016). Detection aristolochic acids 1 and 2 in costustoot via electrochemical method and liquid chromatography. Int. J. Electrochem. Sci.11 (8), 6830–6837. 10.20964/2016.08.11
144
ZhangL.LecoqM.LatchininskyA.HunterD. (2019). Locust and grasshopper management. Annu. Rev. Entomol.64 (1), 15–34. 10.1146/annurev-ento-011118-112500
145
ZhangR.HaoJ.WuQ.GuoK.WangC.ZhangW. K.et al (2020). Dehydrocostus lactone inhibits cell proliferation and induces apoptosis by PI3K/Akt/Bad and ERS signalling pathway in human laryngeal carcinoma. J. Cell. Mol. Med.24 (11), 6028–6042. 10.1111/jcmm.15131
146
ZhangL.XiaoY.YangR.WangS.MaS.LiuJ.et al (2021). Systems pharmacology to reveal multi-scale mechanisms of traditional Chinese medicine for gastric cancer. Sci. Rep.11 (1), 22149. 10.1038/s41598-021-01535-5
147
ZhangL.FanH.PanX.HanZ.TianC.SchneiterR. (2025). Comparative multi-omics reveals phenylpropanoid pathway activation in resistant poplar species challenged by Cytospora chrysosperma. Ind. Crops Prod.234, 121620. 10.1016/j.indcrop.2025.121620
148
ZhengJ.-m.ShangM.-y.WangJ.-l.DaiG.-n.SongJ.-y.DuanB.-z. (2022). Research progress on chemical constituents, pharmacological effects and clinical applications of Aucklandiae Radix and prediction analysis on Q-Marker. Chin. Traditional Herb. Drugs53 (13), 4198–4213. 10.7501/j.issn.0253-2670.2022.13.033
149
ZhouQ.ZhangW.-x.HeZ.-q.WuB.-s.ShenZ.-f.ShangH.-t.et al (2020). The possible anti‐inflammatory effect of Dehydrocostus lactone on DSS‐Induced colitis in mice. Evid.-Based Compl. Alt.2020 (1), 5659738. 10.1155/2020/5659738
150
ZhuangK.XiaQ.ZhangS.MaharajanK.LiuK.ZhangY. (2021). A comprehensive chemical and pharmacological review of three confusable Chinese herbal medicine—Aucklandiae radix, Vladimiriae radix, and Inulae radix. Phytother. Res.35 (12), 6655–6689. 10.1002/ptr.7250
Summary
Keywords
Aucklandia lappa Decne., Aucklandiae Radix, Chinese medicine, applications, Muxiang (Radix Aucklandiae)
Citation
Chen J, Zhao Z, Lin L, Wang G, Yang H and Wang X (2025) Aucklandia lappa Decne.: a review of its botany, cultivation, ethnopharmacology, phytochemistry, pharmacology, and practical applications. Front. Pharmacol. 16:1659831. doi: 10.3389/fphar.2025.1659831
Received
04 July 2025
Accepted
03 October 2025
Published
13 October 2025
Volume
16 - 2025
Edited by
Wei Peng, Chengdu University of Traditional Chinese Medicine, China
Reviewed by
Qiping Zhan, Nanjing Agricultural University, China
Ziwei Yue, Beijing Forestry University, China
Updates
Copyright
© 2025 Chen, Zhao, Lin, Wang, Yang and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zilong Zhao, bigdragonbrother@163.com; Xinghua Wang, wangxh@utar.edu.my
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.